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I. GENERAL INTRODUCTION 
Since drug addiction touches upon many areas of human en-
deavor (sociology, law, medicine, etc.), it has been difficult 
to develop a definition for the term which is acceptable to every-
one concerned. The most generally accepted definition was formu-
lated in 1950 by the Expert Committee on Drugs Liable to Produce 
Addiction of the World Health Organization. This committee defined 
the term as follows (1950): liDrug addiction is a state of periodio 
or chronic intoxication, detrimental to the individual and to 80ci-
etY3 produced by the repeated consumption of a drug (natural or 
synthetiC). Its characteristics include: (1) an overpowering desirE 
or need (compulsion) to continue taking the drug and to obtain it 
by any means; (2) a tendency to increase the dose; (3) a psychic 
(psychological) and sometimes a physical dependence on the effects 
ot the drug. 1t 'fo clarify the distinction between addiction and 
habituation (habit)~ this committee subsequently reported (1952) 
that habituating drugs never produce compulsive craving~ can be in-
terrupted after chronic administration without significant physical 
or psychological disturbances, and cause no sociological damage. 
Two terms used in the above definition, psychic and physical 
dependence, require further clarification. Psychic dependence or 
emotional dependence is hard to define, but, according to Wikler 
(1953)1 means simply that the addict feels discontented or behaves 
as if he feels discontented, or anxious or unhappy unless he 1s 
under the influence o£ a drug. On the other hand, physical depend~ 
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ence refers to the development of an altered physiologic state~ 
consequent to repeated use of a drug over a period of time, which 
requires continued ~inistrat1on of the drug to prevent the 
appearance of a characteristic illness 3 termed an abstinent syn-
drome. 
Although the term tolerance is not specifically mentioned in 
the definition, it is implied by the words titendency to increase 
the dose." Tolerance refers to the progressive diminution in the 
intensity of the pharmacological effects evoked by the same dose 
of a drug during continuous and regular use (Wik1er, 1953)0 
According to Tatum and co-workers (1929), tolerance is an altered 
physiological state induced by the chronic administration of cer-
tain drugs such that progressively larger and larger quantities 
are required to produce the effects desired. Thus, it would 
appear that the development of tolerance is an important compo-
nent of drug addict1on, according to the definition cited above. 
Several additional aspects of the definition tor addiction 
should be mentioned. Addiction usually involves abuse or improper 
use of drugs. Also, it should be noted that although physical 
dependence is generally a eha~acteristie of add1ction, according 
to the definition of the World Health Organization, it 1s not a 
necessary feature. Isbell and Fraser (1950) emphasized that any 
definition which makes physical dependence an essential feature 
of drug addiction will exclude 'cocaine, marihuana, and certain 
sympathomimetic amines (eQg. amphetamine) as add1cting drugs, since 
little or no physical dependence develops to these agents. The 
word "periodic· is included in the first sentence of the defi-
nition for addiction, beeauae cocaine and marihuana are used by 
drug addicts a8 "apree" drugs and are Dot taken continuously. 
Ao The Etiology of Addiction 
Despite the numerous studies on the subject, the etiology of 
drug addiction i8 not clearly understood. Psychiatric and psycho-
logic studies on drug addicts (Pe.cor, 1938, 1941; Reichard, 1943, 
1947; Vogel et &1., 1948; Wikler 1953) indicate that a personality 
detect i8 the most important factor which predisposes an individual 
to addiction. The types ot personalities which usually underlie 
drug addiction were originally classified by Kolb (1925) and Kolb 
and Ossenfort (1938) into 6 groups and subsequently limited by 
Felix (1944) to 4 general classeso The first class, which com-
prises a very small percentage of addicts, consists of normal 
individuals aCCidentally addicted as the result of legitimate 
therapeutic use of a drug. These individuals are often referred 
to as medical addicts. Although these individuals may not appear 
to have personality defects, Vogel and co-workers (1948) are of 
the opinion that they do have fundamental emotional problems which 
cause them to continue the use of drugs beyond the period of medical 
need. Henee~ according to these authors, there 1s no basic differ-
ence between these so-called medical addicts and the non-medical 
addicts. The second elaa. conslst. of psycnoneurotics who take 
drugs to relieve variOUS symptoms, whether somatic or psychic. 
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The third class consists of psychopathic inferiors who are gener-
ally emotionally undeveloped aggressive hostile persons. Trlese 
individuals take drugs merely for the pleasure arising from the 
unconscious relief of inner tension. The fourth and smallest 
class consists of addicts with associated minor psychoses. Major 
/ 
psychoses apparently play no role in the genesi.s of drug addic-
tion (Isbell, 1950a). In general$ a vast majority of drug addicts 
have difficulty in making a satisfactory adjustment to life. 
-
Their adaptive patterns of behavior are inadequate and they fre-
quently find in drugs a means of escape from the stresses and 
problema of life. 
B. Addicting Drugs 
On the basis of the definition for addiction as set forth by 
the World Health Organization, Isbell and White (1953) consider 
the following agents aa the important addicting drugs in the United 
States: (1) opiates and synthetic analgesics (op1um, laudanum. pare-
goric, morphine and morphine derivatives. methadone, and meperi-
dine); (2) hypnotic and sedative drugs (barbiturates. chloral hy~ 
drate, paraldehyde~ and bromides); (3) alcohol; (4) cocaine; 
(5) certain sympathomim.etic amines (amphetamine and methampheta"", 
mine); (6) mescaline (peyote) and (7) marihuana. 
Co Symptoms of Addiction 
Since the various drugs listed above differ in symptoms of 
intoxication and abstinence~ it 1s of interest to describe the 
general effects of these agents. Addiction to morphine may be 
considered as a prototype of addiction to narcotic-analgesic 
drugs. The symptoms of opiate addiction have been described by 
numerous authors (W1kler" 1953; Goodman a.nd Gilman, 1955; Isbell, 
1950a, 1950bJ Isbell and Fraser .. 1950z Himmelsba.ch .. 1941; Is'bell 
and White, 1953). Addiction to opiates is characterized by 3 
closely interrelated phenomena: psychic dependenc8 6 physical 
dependence, and tolerance. When an addict first begins the use 
of opiates he experiences a pleasant relaxation and develops a 
peculiar semisomnolent state with brief alternating periods of 
light sleep and wakefulness. It the drug is administered intra-
yenously, a pleasurable tingling spreads over the body. This 
sensation has been co.pared to a sexual orgasm, localized in the 
abdominal region (Wikler, 1952)0 As the addict becomes toler-
ant, his temperature and blood pressure which were previously re-
duced by the drug and his respiratory and pulse rates which were 
previously lowered return to normal o His semisomnolent state dis-
appears and, if he obtains an adequate supply of drug, his overt 
behavior appears normal and he can carryon his occupation or pro-
fession satisfactorily. The only signs of addiction which may be 
observed in such an individual are needle marks, constricted 
pupils, and decreased libido. When morphine is abruptly withdrawn 
a series of symptoms appear which reach a peak intensity approxi-
mately 48 hours after the last dose of drug. ~he character and 
severity of the abstinence syndrome depend mainly on the intensity 
of pbysical dependence, which is in turn associated with factors 
such as total daily dose used, the frequency o.f drug adminis-
tration, and the health and personality of the addict. Symptoms 
of morphine abstinence include lacrimation, rhinorrhea, perspi-
ration, yawning, restlessness, nervousness, gooseflesh, mydriasis, 
mild hypertension, hyperpnea, fever, leukocytOSiS, and hypergly-
cemia. The addict becomes very uncomfortable; he experiences 
muscle cram~8, muscle tremors or twitching, nausea, and vomiting. 
He experiences diarrhea and loses from 5 to 15 pounds of weight 
in 24 hours. Approximately 1 week after the final dose of morphine, 
most of the symptoms of withdrawal disappear. About 6 months is 
required for physical recovery, as indicated mainly by recovery 
of original body weighto Abstinence from the other narcotiC anal-
gesics differs from morphine abstinence chiefly in the time course 
and intenSity (Isbell, 1950a). 
In general, the effeets of chronic intoxication and abstinence 
produced by the various central nervous system depressant agents 
are very similar (Seevers, 1958; Isbell and White, 1953); there-
fore, barbiturate addiction can be discussed as the prototype of 
addiction to this class of agents~ including ethyl alcohol. There 
1s a large number of experimental and clinical reports to indicate 
that if large doses of barbiturates are taken chronically, toler-
ance and physical dependence develop and a characteristic with-
drawal syndrome appears when the drug is suddenly stopped or the 
dosage markedly reduced. (Dunning~ 1940j KallnowBky~ 1942; 
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lsbell# Altschul et al.# 1950J Fraser and Isbell~ 1954; Fraser 
et &f •. 1 1954; Isbell and White 1953; Isbell, 1950Q# 1950b, 1951). 
Although the long-acting barb1turates are sometimes used by 
addlcts# the potent short-acting agents, pentobarbital, seco-
barbital, and amobarbital are more popular. Chronic intoxi-
cation with barbIturates results in impaired mental funct1on# 
10S8 of emotional control, poor judgment # confusion# and, occs-
slonally# a toxic psychosis. Also, nystagmus, dysarthria, 
ataxia, and adiadochokinesia are prominent s1.gns. Individuals 
who are addicted only to barbiturates continue to eat and to 
maintain a good state of nutrition. The respiratory rate and 
minute volume are not greatly depressed and coma is uncommon. 
Partial tolerance to the barbiturates develops, but it is never 
complete; thus, tolerance to the lethal effect of barbiturates 
does not develop. Upon abrupt cessation of the barbiturate, 
intoxication initially declines and the addict appears to im-
prove. Then he experiences anxiety, nervousness# tremor, weak-
ness, impaired cardiovascular responses# and muscle tremors. 
APproximately 2 days after withdrawal from a short-acting bar-
biturate or about 1 week after withdrawal from a long-acting 
agent many addicts experience grand mal type convulsions. Other 
addicts may experience insomnia which culminates in delirium. 
Agitation may lead to extreme exhaustion and death (Fraser et ~l, 
1953). Chronic ethanol intoxication differs somewhat from bar~ 
blturate intoxication in that there are usually nutritional dis-
turbances associated with the former situation. Also~ cirrhosis 
of the liver frequently occurs in chronic alcoholic persons. 
Addiction to other aliphatic hypnotics such as chloral hydrate 
and paraldehyde is not a problem in the United States (Isbell and 
Whlte~ 1953; Seevers» 1958). According to the review of Poh11sch 
as cited by Kalinowsky (1942) and Dunning (1940), the sympto-
mology of intoxication and withdrawal of chloral hydrate and par-
aldehyde resembles that of alcohol and the barbiturates. Bromide 
addicts show psychic dependence, but apparently do not develop 
tolerance or physical dependence (Vogel et al,o, 1948; Isbell and 
White, 1953). 
Cocaine 18 oapable of causing psychic dependence (Vogel 
at a1 0 $ 1948), but does not induce phys1cal dependence or toler-
ance (Vogel at ~., 1948; Seevers, 1958; Tatum and Seevers 6 1931)0 
When the drug is taken intravenously, it produces an orgastic sen-
sation which prompts the addict to repeat the injection of cocaine 
at very short intervals in order to experience this ecstasy as 
often as possibleo As the dose is repeated the toxic effects of 
cocaine accumulate and a characteristic psychosis develops9 The 
toxic effects of cocaine are so unpleasant that there are few pure 
cocaine addicts in the United States. 
The symptomology of i.ntox1catlon to the sympathomimetic am1nes 
resembles that of intoxication to cocaine (Isbell and White; 1953; 
Freyhan~ 1949)0 Tolerance develops rapidly to the drug and$ except 
for weakness and depreSSion (Monroe and Drell, 1947) and somnolence 
(Knapp, 1952 ), there 1s no pronounced symptoms of abstinence. 
Marihuana. is. used mainly as a. "spr)ee lnl drug. In fl, chronic 
ex.periment in huwln subjects ~ Will1all18 Bind cO=-1Yl0rkers (1946) 
showed that the principal effects of mH,l'ihuana were initial ex-
hilaration and euphoria followed in ~l fe~j days by general las-
situde and ind1fferenceo In isolated insta,nces, marlhuaona. may 
produce bizarre effects of an antlsocia,l nature. A small degriee 
of tolerance was demonstrated by the fact that the initial loqua-
ciousness a.nd gaiety, which lasted only a re~1 dctys, could be re-
captured by incli)easing the dose of marlhuana", HOlfever" no ph:ysl-
cal dependence was demonstrated o 
The use of peyote is almost exclusively associated with 
rellgious a.ctivities of certain Indian tribes in the United Sta.tes 
and Mexico. Intoxication with peyote or Dlescaline resembles tha.t 
with marihuana (Walton$ 1938)e The ingestion of peyote results in 
visual 8 .. nd a.udi tory hallucinations (Hoch" 1952). As fa.r as is 
mown, tolerance does not develop to mescaline and there a.re no 
withdrawal symptoms (Isbell and White, 1953)0 
Do Experimenta,l PJi.ddlctlon St'udies 
In the study of add,ic tion llab111 ty of var>iolls agan ts, humans 
a,s well as lnfrahuwin species havt,} been employed. The literature 
on experimental morphine addiction has been extensively reviewed 
by Eddy (1941). The principal components wllieh may be investi-
gated experimentally are psychic dependence" physical dependence, 
and acquired tolerance. Seevers (1948) and Isbell (1948) have 
emphasized that psychic dependence must be determined in mftn" and 
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pointed out that clinically applicable inrormat1on from animals 
is limited to studies ot tolerance and physical dependence. The 
nature of the abstinence syndrome observed depends upon the 
physical characteristics ot the species and the phylogenetic 
development of the central nervous system (Seevers, 1948). In 
the lower species, generalized hyperirritability is the only 
constant sign of withdrawal. 
In the use of human subjects tor addiction liability stud-
1es~ 2 general approaches are available for the investigation of 
narcotic analgesics. The first approach involves the use of 
patients with intractable pain who require relief for long peri-
ods (Isbell and Fraser, 1950). Low doses of analgesics are given 
to these subjects and a low grade of dependence 1s produced. The 
results obtained from this type of study are difficult to inter-
pret and the conclusions derived therefrom are unrelie,ble. For 
example. sach analges1cs as heroin l d11audid, meperid1ne l and 
methadone l have been Judged to be non-addicting by this technic. 
The second approach involves the use of F'ederal prisoners who 
are aetive- or post~morphine addicts; this type of study 1s per-
formed mainly at the Public Health Service Hospital~ Lexington, 
Kentucky.. The 4 procedures emp~oyed at Lex1ngton have been re-
viewed by Isbell (1948). The £irst of these technics is related 
to the production of euphoria by a Single dose of the analgesic; 
such signs as increased talkat1veness~ boasting, increased motor 
activitYI etc. are considered as indicative of euphoria. The 
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second technic consists of determining the ability of the test 
agent to relieve abstinence from morphine in addicted subjects. 
The hourly pOint score system of Himmelsbach (1937) is employed 
to quant1tate the intensity of the withdrawal symptoms; if the 
test agent has the ability to reduce the severity of or abolish 
morphine abstinence, it is fairly likely that it is capable of 
producing physical dependence. The third method involves the 
abrupt subst1tution of the new drug for morphine in addicts. rr 
the test drug is capable of supporting the addict and if with-
drawal symptoms appear upon abrupt termination of drug adminis-
tration, it is regarded as having physical dependence liability. 
The fourth method involves the chronic administration of the test 
agent to post-addicts in an attempt to induce direct addiction. 
The drug' is' admin1s'tered' at·- the' appropriate in terv'sls ea.ch day and ' 
the dosage 1s 1ncreasedfrom. time to time aoeo'rd1ng ,to the subject'8 
tolerance to the toxic effect of the drug. After a suitable period 
of chronic trea.tment, the drug is abruptly withdrawn a.nd the sub--
Ject i8 observed for abstinence symptoms. Of the 4 methods men-
tioned. the direct addiction procedure 1s considered the best 
(Isbell" 1948), for it yields information in regard to psychic de~ 
pendence~ a8 well as to tolerance and phys1cal dependence. The 
Lexington group has also investigated in human subjects the addlc~ 
tion liability ot various central nervous system depressants, par-
ticularly barbiturate (Isbell, Altschul at aI o , 1950) and alcohol 
(Isbell et al., 1955)0 These experiments have consisted mainly 
of: direct addiction studies o' 
According to Kolb a.nd Du Mez (19~1) Seevers (1948) the 
monkey 1s probably the best infrahuman species to use for anal .... 
gesic addiction lia.bility experiments., beceus·e the signs of 
abstinence in this species are very s1.m11ar to those observed in 
man. The abstinence symptoms in the monkey ha,ve been described 
in detail by Seevers (1936). 
A la.rge number of experimental a.ddiction ::,tudles ha.ve been 
per.formed on the dog., The symptom~l of mO.rphlne addie tiorl a,nd wi th ... 
drawal in this species a.re also similar to those of D18"n and have 
been described by Plant and Pierce (1928). Seevers and Tatum 
(1931) reported that dogs chronically intoxicated with barbitura.te 
showed to1era,nce and signs of abs tinence I including convulsions. 
Fraser and Isbell (1954) confirmed these observations 8/nd further 
reported a ca.nine type of delirium during barb1 tUI~ate abstinence. 
There have been but :few a,ddlction lis,bill ty studies in lJihich 
ca.ts have been employed as test anima.ls. Those that have b,e'en re= 
ported indicate confl1cting results o For e:xample;j Gold (1929) and 
Eddy and Hlmmelsba,ch (1936) reported the development of tolera.nce 
to the excltatorJ Y effects o til IrLorphlne in the C,9~t~ wheree,s Tatum, 
Seevers" and Collins (1929) re;ported increased re,therJ than de= 
creased excitement o Gold (1929) also reported tha.t cats chroni= 
cally treated with morphine shewed drowsiness a.nd loss of e1ppe-
t1 te as the only signs of abstinence o Recently, Tavat and ft.k~a3u 
(1956) studied the excitant effects of a. series of 8,nalgeslcs on 
cats. They reported e, parallel relation tween the ability of 
the drugs to cause addiction and the ability of an acute dose to 
produce excitation in cats, and suggested that the intensity of 
the excitant effect of new analgesic compounds might be used as 
an indication of their relative addiction liability. 
The rabbit haa been used not infrequently for addiction 
studies. Although numerous investigators reported the development 
of tolerance to morphine in this spee1es~ Tatum and co-workers 
(1929) and Eddy (1941) claimed that in rabbits, tolerance to the 
depressant effect of morphine either develops only to a slight 
extent or not at allo The information regarding withdrawal sym~ 
ptoms in rabb1ts 1s also conflicting (Eddy 1941). Since the rab-
bit shows a gradual decrease in the hyperglycemic response to re~ 
pea ted injections of analgesics and temporary hyperglycemia dur-
ing withdrawal, Phatak, Maloney and David (1948) suggested that 
this response might be useful for estimating addiction potenti-
alities of analgesic compounds. 
Barlow (1932) described a method for evaluating in rats the 
tranquilizing potency of a series of narcotic analgesics o This 
procedure was adapted by H~elsbach and co~workers (1935) and 
modified by Eddy and Himmelsbach (1936) for 8.dd1etion 8 tudies 0 
The technic consists of lashing rats in the supine position and 
measuring the amount of struggle (irritability) before and after 
a daily dose of drug o Tolerance is indicated by an increase in 
the post-injection struggle during successive weeks of chronic 
drug administrat1on; addiction (physical dependence) 1s indicated 
by an increase in the pre-injection struggleo Hl,mmelsba,ch and 
co-workers (1935) detected tolerance and phys1cal dependence to 
a number of analgesics, including morphine, by this technic. 
However, Shideman and Seevers (1941) were unable to reproduce the 
results of Himmelsbach and associates during chronic morphine 
treatment of 8 weeks dUI'ation o Stanton (1936) employed Barlow~s 
procedure to determine the effects of daily barbiturate admini-
stration., He reported that dally injection or up to 23 mg/kg of 
sodium phenobarbital or 36 mg/kg of sodium pentobarbital did not 
result in addiction (physical dependence) and tha.t slight toler-
ance developed only to the largest dose of pentobarbital admini~ 
stered. Seevers (1954) questions the significance of results ob-
tained in rats. 
Mice have been l1ttle used in addiction liability studies. 
Daily injection of morphine in white mice results in a shorter 
duration (Eddy~ 1941) ~ also a decrease in incidence (Nadzel, 
1937) of the Straub responae o Recently, McQuarrie and Fingl 
(1958) employed electroshock and chemoshock procedures to detect 
alterations in central nervous system excitability in mice follow~ 
ing acute and chronic ethanol administration. Chronic ethanol 
adm1nistra.tion decreased centra.l nervous system excitability, a.s 
indicated by an increase in seizure threshold, whereas~ abrupt 
wlthdrawal of ethanol increased excitability, as indicated by a 
decrease in seizure threshold o These investigators suggested that 
these technics might be useful in the study of tolerance and physi~ 
cal d.ependence to central nervous system depressants. 
II. STATEMENT OF THE PROBLEM 
Considerable evidence has accumulated which indicates that 
large doses of meprobamate (MiltoWD, Equanil) may induce addiction 
to this drug. Barsa and Kline (1956) reported that 6 of 25 schizo-
phrenic pat1ents, who received meprobamate (2400 mg/day) for 9 
months. had convulsions following abrupt withdrawal of the drug. 
Lemere (1956) noted that a patient who had been taking 6 0 4 g of 
meprobamate daily for a month experienced a seizure 10 hours after 
discontinuing medicationo Tucker and Wilensky (1957) administered 
meprobamate to 32 schizophrenie patients for 12 weeks (1600 mg/day 
for the first 2 weeks, 3200 mg/day for the next 2 weeks, and 4800 
mg/day for the remainder of the experimental period) and reported 
that 2 of the patients had grand ~~ seizures when the therapy was 
a.bruptly terminated 0 Ewing and. Fullilove (1957) slowly wi thdrew 
meprobamate (by diminishing the dose over 5 days) from a patient 
who had been taking 4000 to 8000 mg of the drug daily for several 
months and observed twi tch1.ng of the leg during the period of 
withdrawal. The patient» who was formerly addicted to papaveretum 
(Pantopon), considered withdrawal symptoms of meprobamate worse 
than those of opium alkaloids o 
In view of the above clinical report8~ it seemed important 
to study in laboratory animals the addiction potentiality of 
meprobamate and other related agents. Seevers (1948) and Isbell 
(1948) have emphasized the difficulty of evaluating psychic de~ 
pendence in laboratory animals and have pointed out that addiction 
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studies in subhuman species must necessarily be limited to the 
deter~~nation of tolerance and physical dependence. Since 
McQuarrie and Fingl (1958) have reported that electroshock and 
chemoshock procedures can be employed to demonstrate phys1cal 
dependence to alcohol in mice, it was thought important to 
ascertain whether these technics could be used as a measure of 
tolerance and physical dependence to other agents in this 
species. It was appreciated that negative results obtained with 
these technics would not rule out the possibility that addiction 
liability exists. Positive results, on the other hand, would be 
highly suggestive that the agent should be held suspect until 
clinical trial proves otherwise. 
Because both meprobamate and phenaglycodol (Ultrsn) are 
substituted diols a~d have similar pharmacological activities 
in experimental animals (Berger, 1954; Slater et al. 1 1956) 
and in view of the lack of evidence that the latter drug is 
capable of indUCing tolerance and physical dependence, it 
seemed desirable to include phenaglycodol in this stud.y. 
Since both meprobamate and phenaglycodol are known to in-
crease seizure threshold (Chin, 1957) and are known to have anti-
convulsant activity (Perlstein, 1956; Gruber and Mosier, 1957), 
it was thought important also to include an agent known to de-
crease seizure threshold o Hence, promazine, which has been re~ 
ported to decrease minimal electroshock seizure threshold 
(Tedeschi et al. 1 1958; Fink, 1958) and to induce seizures in 
susceptible patients during therapy (Hankofr ~~ al., 1957; Barsa 
and Kl1ne# 1957; Voegele and May, 1957; Kurtzke, 1957; and Fazekas 
at al., 1957), was investigated to ascerta.in whether chronic ad-
ministration of this drug and its abrupt withdrawal would evoke 
abstinence symptoms opposite to those observed upon the withdrawal 
. of meprobamate and phenaglycodolo 
In view of the apparent role of electrolyte metabolism on the 
excitability o~ the central nervous system of laboratory animals 
(Davenport, 1949; WoodburY3 1952 $ Woodbury and Davenport, 1949; 
Woodbury et al. 3 1957) Timlras et alo~ 1954; Swinyard et ~Ol 1955; 
Timlras et al., 1955; T1miras and Woodbury, 1956) the brain electro-
lyte concentration of meprobamate- and promazine-treated mice were 
determined in an effort to elucidate further i it possible, the 
mechanism or tolerance and physical dependence which follows chronic 
drug administration. 
III ~ GENERAL PROCEDURES 
The following procedures were eaployed in all experiaent8 0 
Adult .ale albino aice obtained fro. the Carworth Faras (CF no. 1 
8train) were u8ed aa experi.ental animals. They were maintained 
on Rockland Mouae Diet and were allowed free access to food and 
water except for the short periods they were reaoved fro. their 
cages for testingo 
The low=frequency electroshock 8eizure threshold (EST) was 
determined in aice by means of a Grass stimulator (aodel (54B). 
The stiaulus paraaeters employed were described by Brown and co-
workers (1953) and consist of unidirectional pulses of O~2 mil-
lisecond duration delivered for 3 seconds at a freq~ency of 6 
pulses per secondo A drop of lodiwa chloride solution (Oo~) 
was instilled into each conjunctival sac, the electrodes were 
held in contact with the corneas and the 8ti.ulu~ was adminis-
tered. The animal was then observed for signs of a seizureJ a 
"stunning" effect in which a mouse remains motionless for 7 
seconds was taken a8 a ainimal positive relpon8e~ The experi-
.ental design of McQuarrie and Fingl (1958) was employed to 
study central nervous systea excitability. For each determi-
nation 2 groups of aice were u8ed~ a drug=treated group and a 
control groupo Mice were shocked at Yario •• voltagea selected 
by the staircase procedure (FinneYI 1952)~ the voltage required 
to evoke convulsions 1n 50% of each group was determined and 
the 95~ fiducial liaits were calculated by the method of 
Litchfield and Wilcoxon (1949)0 The results, presented as the 
electroshock seizure threshold rQtlo (threshold of drug group/ 
threshold of control group)$ were computed by the method deacribed 
in Append1x B. 
Pentylenetetrazol seizure threehold (PST was deteralned in 
mice by the technic of Orloff and co~worker. (1949) as modified 
by McQuarrie and Fingl (1958)0 The convulsant ~olut1on, composed 
of 005% pentylenetetrazol» 009% sodl'w. chlorlde a and 10 ug/al of 
heparin sod1um, W&8 infused into the tail vein at a constant rate 
of 0.005 .1 per second by means of the apparatus designed by 
Gabardl and Esplin (1951) until the aouae exhib1ted persiatent 
clonua for 3 aecondso The body weight and the pentylenetetrazol 
infusion tiae (the tiae in seconds from the start of the inf •• ion 
until the endpoint was observed) were recorded to the closest 0.5 
g and 0.5 second, reapect1yely~ for each anl.alo The data ob-
tained for groups Qf drug~treated and control alce were 8val.ated 
by analysis of covariance (Finney, 1952)0 The resulta i pre-
sented as the pentylen6tetrazol ~elz.re threshold ratio (thres-
hold of drug group/threshold of control grouP)a were computed by 
the aethod described in Appendix B. 
Since the present studies were planned to deteraine whether 
tolerance develops during the chronic adainiatration of the candi~ 
date drugs and whether abrupt withdrawal 1s followed by alteration 
of the excitab1lity of the central nervous system, high dose 
levels of drugs were eaployed o The dose. selected produced defi~ 
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n1te toxicity (eogo ataxia), but not to a level which prevented 
the anlaals fro. eatingo Deneau and eo=workers (1954) and 
Seevers (1954) have emphasized that to provide optl.al con~ 
dltlon8 for the developaent of tolerance and physical de~ 
pendenee it 1. necessary to maintain a high tissue eoncentra~ 
t10n of dr~g continuously by adjusting the frequency of drag 
adalniatration according to the d.rat1on or actlono Thus, in 
the studies reported herein the drugs were ada1nistered at 
intervals corresponding to the d~ratlon of drug action as deter-
mined by tox1city studies or by the EST teat. Meprobamate and 
phenaglycodol were suspended in ~ acacia solution, whereas 
promazine was dissolved 1n distilled watero All te~t dr.ga 
were given orally in concentrations such that 10 aI/kg body 
weight of the a.~pen81on or solution contained the appropriate 
dose of drug~ 
The threshold altering effeets of the test agents were 
deteralned at the ti~ of peak drug action as &acertained by 
the EST or PST te3to The effects of withdrawal on central 
nervous systea excitability were determined by these teats at 
tiae intervals corresponding to the estl.ated d~ratlon ot drug 
aetion and~ 8ubaequentlYa at intervals of 24 hours and 48 hours 
for approxlaately 1 week. 
IV 0 THE EFFECTS OF CHRONIC AND ACUTE 
ADMINISTRATION OF PSYCHOPHARMACOLOGICAL AGENTS 
ON CENTRAL NERVOUS SYSTEM EXCITABILITY OF MICE 
Ao The Effects ot Meprobaaate (Miltown, Equanl1) 
on Central Nervous System Excitability of Mice 
10 Introduction 
The well=known s1d~ effects and potential "behavioral toxic1ty" 
(Kline, Barsa» and Gosline~ 1955$ Dickel and Dixon, 1957) of the 80-
called "tranquilizing agents" Justify concern over their 1nd.1sc. 
cr1.inate use. The added possibility that some of these drugs aight 
also possesB addiction liability was .uggested by the original clin-
ical reports of BarB& and Kline ('1956) and Lemere (1956)0 These re-
ports indicated that tolerance develops to the effects of mepro~ 
boaate (Miltown$ Equan11) and that abrupt withdrawal in patients 
who have chronically ingested large doses of the drug may preclpl-
tate nervou8ness 9 insomnia s and convu181onso In view of these re-
ports, the effects of the chronic ada1nistratlon of this agent and 
its abrupt withdrawal on the exc1tability of the central nervous 
systea of mice were studiedo 
20 Methods 
Chronic administration of .eprobaaa~e (EST teat). One 
hundred alce.9 25 to 35 g in weights were randoll.l¥ divided into! 
equal gro.ps. Meprobamate was administered orally as a suspension 
in ~ acacia solut.1on. Th~ drug wa~ initially given to 1 group of 
~ce in a total dally dose of 1200 mg/kg (200 mg/kg at 8 a.m., 
12 noon, 4 PO.OR and 8 Po.o» and 400 as/kg at midnight) for 6 days. 
Following the 8 &0.0 treat.ent on day 1~ each dose was increased 
by 50% to make a total daily dose of 1800 mg/kS$ this higper dose 
level was continued tor 10 day3~ except &8 indicated in the legend 
to flgare 1. The other group served as a control and was g1yen 
the requisite voluae of ~ acacia solution at the appropriate inter-
vals o Lew~frequeney electro~hock 8e1zure thre8hold ratios were 
determined at the tiaes indicated in the legend to figure 1. 
Ac.te ada1nistration of meprobamate (EST test). Eighty 
.lee l 22.0 to 36.5 g in weight~ were randomly divided into 2 equal 
groups. One group was g1ven orally 300 mg/kg of meprobamate, and 
the other group the requisite volume of ~ acacia solution; the 
EST ratio was determined at selected times after drug treatment. 
This procedure was repeated at intervals of 3 or 4 days in the 
sa .. groups of aiee until EST ratlo3 were established 1/2, 1, 2, 
3, and 4 hours after drug adm1ni$trat1ono 
Chronic adainistrat1o~or aeprobamate(PST tea~o 
Twenty~s1x mice, 2305 to 30$0 g in weight~ were randomly divided 
into 2 equal gro.pso The d08e ~~hedule for 1 group of aice was 
identical to that described for the chronic study which employed 
the EST test, except that the initial dose leyel was given for 7 
da~s and each dose was increased 50% following the 8 &0.0 treat~ 
aent on day 8 instead of on day 7~ also, the larger daily dose 
was continued for only 7 day~ as indicated in figure 20 The 
other group served as a control and was given the requiaite voluae 
of 6% acacia solutlon o Minimal pentylenetetra,zol seizure thres-
hold ratios were determined at the tlaea indicated in the legend 
to figure 2. 
!,cute ~1ni~t~~~. of lI.eprobam!,te (PST t~st). F'orty--
eight mice, 24.0 to 34.5 g in weight, were randomly divided into 
4 equal groups. Two group~ were given orally a single dose of 
300 as/kg of meprobaaate, and the other two groups the requisite 
VOlUBle of acacia solution. Pentylenetetrazol seizure threshold 
ratios were determined at 8elected t1aes after drug ad~nistrat1on. 
This procedure was repeated at intervals of 6 10 days antl1 PST 
ratios were established 1/2, 1, 2, 49 and 6 hours after drug ada1n-
lstrat.iono 
3. Results 
EST tes~o Adain1strat1on of a single 300 as/kg d0se of 
meprob8Jl.8.te to non .... tolerant mice lncreased the electroshock seizure 
threshold more than 10 fold 1/2 hour after drug treatment (see in .... 
set in .figure 1) a wher~aa, after chronic trea tmen t for 6 days w1 th 
1200 mg/kg/day and then for 10 days with 1800 mg/kg/day, this same 
dose of drug increased the threshold only 2 05 .fold (see A, day 13, 
figure I). Thus, tolerance develops to the EST=raising effect of 
meprobamate. Figure 1 al~o 8hows that 4 hours arter the 8 a.m. 
dose on day 12 and 4 hours after drug withdrawal on day 17 (see B 
and E, figure 1), the EST in mice chronically treated with .epro~ 
bamate was somewhat le~s than 008 that of control animals. Hyper~ 
excitability wa~ also observed 8 hours after the double midnight 
dose on day 13 and 8 hours after the 8 &omo dOBe on day 14 (see C 
and D, figure 1). Since EST was not reduced 4 hour$ after the 
adainistrat10n of a Bingle 300 mg/kg dOBe of meprobamate to non= 
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Figure 1. Effects of chronic administration of meprobamate 
on threshold for low-frequency electroshock seizures in mice. 
Time in days is indicated 9n the abscissa. Seizure threshold 
ratio (threshold drug group/threshold control group) is shown on 
the upper ordinate and total daily dose of meprobamate adminis-
tered is shown on the lower ordinate. Vertical bracketed lines 
indicate 95% fiducial lialtse A,B~ and D indicate the ratio at 
l/!~ 4, and 8 hours, respectively, after the 8 a.m. dose; C indi- . 
cates the ratio 8 hours after the double midnight dose; E, F, G, 
HI and I indicate the ratio at 4, 28, 52, 100, a.nd 148 hours, 
respectively, after the final dose of d~~. The inset in the 
upper right-hand corner illustrates tbe duration (hours) of the 
effect of a single dose of meprobamate (300 -S/kg) on 1ow-fre-
quency electroshock seizure threshold in non-tolerant aice. 
tolera.n t animals (see im~~ t in figure 1), the <wi thdrawal hyper-
excitability must be attributed to the chronic administration 
of this drug o 
PST test o As illustrated in figure 2, tolerance also 
developed to the PST=rai8ing effect of m~probamateo This was 
demonstrated by the fact that the PST was increased 4 .. 5 fold in 
non-tolerant mice 1/2 hour after drug treatment (see inset, 
figure 2), wherea.s, after chronic treatment for 7 days with 
1200 mg/kg/day and then for 5 days with 1800 mg/kg/day, the 
saae dose of drug increased the threshold only 2 .. 9 fold (see A, 
day 13, figure 2)0 Figure 2 also shows that 4 hours after the 
8 aomo dose on day 15, the PST ratio in chronically=treated 
animals was only 0.820 Since the threshold ratio after the 
adAini3tration of a single dose of 300 ag/kg to non=tolerant 
animals was 1 (see inset, figure 2), the reduction in the PST 
ratio observed in the chronically=treated animals Auat be attri~ 
buted to the abrupt termination of meprobamate administration. 
4. Discussion 
The data obtained in theBe ifttudle£! indicate that tolera.nce 
and physical dependenc~ d~velop to the chronic administration of 
large doses of meprobamate to) aice o Tolerance i8 shown by the 
fact that the EST~rai31ng effect of 300 mg/kg of meprobamate is 
reduced by at lea.st 75% and the PST~raiaing effect reduced by 
approximately 33% in animals receiving the drug chronically. 
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Figure 2. Effects of chronic ada1nistration or meprobamate 
on threshold tor pentylenetetrazol seizures in mice. Time in days 
is indicated on the abscissa.. Se1.zure threshold ratio (threshold 
drag group/threshold control group) is shown on the upper ordinate 
and total daily dose of meprobaaate administered 1s shown on tho 
lower ordinate. Vertical bracketed lines lndlca,te 95% f1d;uclal 
l1Bllts. A indicates the re,t1.o 1/2 hour s.fter the 8 a.m. dose; 
B" C" D" E, and F indicB.te the ratlo at 4" 28" 52, 100, and 150 
hours, respect1vely, a:fter the final dose of drug. The inset in 
the upper r1ght-band cornet~ lllustra,tes the duration (hours) of 
the effect of a Single dose of meprobaaate (300 as/kg) on pentyl-
enetetrazol se1zllre threshold in non-tolerant mice. 
=21 = 
less pronounced in the treated anima.15 as drug administration 
was continued e Physical dependence is demonstrated by the fact 
that withdrawal hyperexcitability became manifest 4 hour:s after 
the final dose of drug$ the EST= and PST=ratioB of meprobamate-
treated mice was only 0014 (see.E, figure 1) and 0082 (see B, 
figure 2), respectivelyo Also, it was observed that after 
approximately 1 week of chronic meprobamate administration the 
drug=treated aice manifested a pronoQnced degree of prein= 
jection irritability and wera relatively more difficult to intu-
bate than the control &ni.a15 o Since neither the E,ST nor the 
PST was reduced 4 hours a.fter the single administration of the 
same dose of meprobamate to non=tolerant animals (see insets in 
figure 1 and figure 2),9 it mu:st be concluded that the reduction 
in threshold represents withdrawal hyperexcitability attribu-
table to the chronic administration of this drug o 
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B. The Effects of Phenaglycodol (Ultran) 
on Central Nervous System Excitability ot Mice 
1. Introdu.ctio!l 
Studies on meprobamate indicate that tolerance and with-
drawal hyperexcitabilIty result from chronic administration of 
la.rge doses of this drug to mice, as measured 'by electroshock 
and chemoshock technics. Because both meprobamate and phens-
glycodol (Ultran) are substituted d101s and have s~ilar 
pha,rmacolog1cal activi t1es in experimental animals (Berger, 1954; 
Slater at al. 1 1956), it was of interest to determine the efrects 
of chronic admin1stration of large doses of phenaglycodol and of 
1ts subsequent abrupt withdrawal on the central nervous system 
excitabil1.ty in mice. In the absence of positive experimental 
and clinical evidence that this drug 1s capable of inducing 
tolerance and physical dependence, it was anticipated that such 
a study might be of value in predicting the effects of abrupt 
withdrawal of phenaglycodol in patients who have been chronically 
ingesting large doses of the drug. 
2. Methods 
Chroni2-~m';nistration o!_phenaglyc2g..9.~ (EST .test). A 
population sample of mice, 21.0 to 32.0 g in we1ght, were, randomly 
divided into 2 groups of 50 animals each. Phenaglycodol was ad-
ministered orally as a suspension 1n ~ acacia solution. The drug 
was initially ~iven to 1 group of mice in a total daily dose ot 
600 mg/k~ (200 as/kg at 7 a.a., 3 p.m., .,and 11 P.m..).tor 6 days. 
Following the 7 Ilomo t,reatment on day 7 ~ each dose was increased 
by 50% to I1Elke an average total d,al1y d.ose of 900 mg/kg; this 
higher dose level was continued for 11 days.g Q:S indicated in 
figure 30 The other group ~6rved as a, control and was given 
the requis 1 te voluJl.e o.f' BA!;Qcia. a t corresponding in tervala " Low .... 
frequency electroshock ~eizure threBholds were determined for 
both groups at tlhe times ind:tcated in the legend to figure 
and the EST ratio calculated. 
AClJ.te admini8 tra t10n of • A 
population mample of mice, 2600 to 3505 g in weight 3 were randomly 
divided into 2 groups of 40 animals) each. One group was given 
orally 300 II.g/kg of ph~naglycodols aIo.d the other> grou.p was given 
the requisi te volume of 8"cacla Bolutlono Th~e EST or both groups 
was determined at a ~elected time ,after drug trea,tment a,nd the 
EST ratlo calculated o This procedure was repeated at intervals 
or 3 or 4 days in the $ame group8 of mice until ratios were 
obtained 1.9 23 4~ 8 3 12, 16 and 25 hours a.fter drug adJJ.ln1stration. 
Chronic tratlon of A 
population BBlI.ple of micejJ 00 to 2800 g in welght, were ran= 
domly d1 vided into ! e~!ual grou,ps Q Phenaglycodol was ini tially 
glvento 1 group in a total daily dose of 600 mg/kg (200 mg/kg at 
8 a.mo~ 4 PQa O , and midnight) for 8 daysQ On day 9 each dose was 
increased by 50% to PI~ovlde a total daily do~e of 900 mg/kg~ this 
higher dose level wa~ continued for 9 days iJ as lnd:lcated in figure 
4& The other group served as a control and wa~ given the r6quls1te 
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volume of acacia solution at the appropriate intervals. The PST 
of both groups were determined at the times indicated in the 
legend to figure 4, and the ratios calculated. 
Acute administration of phenaglycodol s~!ST test). A 
population sample of 48 mice, 25.0 to 34.0 g in weight, were 
randomly divided into 4 equal groups. Two groups were given 
orally a single dose of 300 mg/kg of phenaglycodol and the other 
2 groups the requisite volume of acacia solution. The PST of 
the 4 groups were determined at a selected time after drug treat-
ment~ and the PST ratio calculated. This procedure was repeated 
at intervals of 6 and 8 days until PST ratios were obtained 1, 4~ 
8, and 12 hours after drug administration. 
3. Re8~lts 
EST test. A s1ngle 300 mg/ks dose of phenaglycodol in 
mice elevated the electroshock seizure threshold 3.7 fold 1 hour 
after drug administration to non-tolerant mice (see inset, figure 
3), whereas, after chronic treatment for 6 days with 600 mg/kg/ 
day and then for 11 days with 900 ms/kg/day, this same dose of drug 
elevated the EST only 1.9 fold (see A, day 16, figure 3). ThUS, 
tolerance develops to the EST-raising effect of phenaglycodol. 
Figure 3 also shows that 8 hours after the 11 p.m. dose on 
day 11, 16 hours after the 3 p.m. dose on day 13 and 8 hours after 
the final dose on day 17 (see B, 0, and D, figure 3), the EST in 
phenaglycodol-treated mice was only 0.81, 0.84, and 0.85, respec-
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Figure 3. Eftects of chronio adm.:tnistr·g,t1on o,f phensglyeodol 
on threshold. for lowcwfrequf)ncy electroshock ae1.zu.res in DUcal. 
Timet in days is lnd1cated on the) absc15~aJ. Seizure threshold 
ratio (threshold drug group/threshold control gr1oup) 1s shown on 
the upper ordinate 8,nd total da1ly dose of phene~glyeodol adm1n11= 
tared 1s shown on the lower ordinate. Vertical bra.eke ted lines 
indica te 95% t1duc18~1 11.1 ts e 11 indioa tag the r",a,t10 1 hour after' 
the 7 a.1I. dose, B ind1cates the ra,t10 8 hours att~".,the 11 p.m. 
dose J C 1ndica tes the rJ~jl, tio 16 hours after the 3 P .!l. dose. Fol-
lowing the 16-nou.r interval" the anillBpls were g1 ve:n.~L dou.ble dose 
of drug i.n order to main ta,in the a.vers,ge daily dose of 900 m.gjkg. 
D" E., F, G, and. H ind.1cate the ratio at 8, 3!, 56, 104, and l52 
hours, respectively, atter the final do~\e of d'!»ug. The 1nl~et in 
the upper r1ght-hsind corner 1l1u~tre..tes the dUtOatlon (hour'.) of 
the etfect of a Single dose o~ phenaglycodol (300 ms/kg) on low-
frequency electroshock seizure threshold in non-tolerant alce. 
hours after adBdn1strat1on of a single dose of 300 mg/kg to non~ 
tolerant aice was still 2.19 fold that of contr·ol animals (see 
insetJ) figure 3) ~ the reduction i.n threshold oba·erJved in the 
tolerant animals must be attributed to the chronic administration 
of phenaglycodol~ 
PST test. The acute administration of 300 mg/kg of 
phena.glycodol to non-=tolerant mice lncrea:sed the PST 704 fold 1 
hour after oral intubation (see in~et3 figure 4)5 whereas, after 
chronic treataent for 8 days with 600 mg/kg/day and then for 6 
days with 900 mg/kg/day, this same dose of drug elevated the PST 
only 4 fi 7 fold (see A fJ da.y 15.9 f1.gUlb8 4) 0 Thus 3 tolerance de-
velops to the PST=ra1sing effect of phenaglycodol o 
Figure 4 also illustrates that 8 hours after the midnight 
dose on day l! and 12 hours after the midnight d088 on day 20, 
PST ratios in the chronically~treated mice were only 0.82 (see 
B and D~ figure 4)0' Since the PST ratio was 2.3 in non~toler~ 
ant mice 8 hours after the administration of a single dose of 
300 mg/kg and was normal at the 12~hour interval (aee inset 3 
figure 4)J) the reduction In sel;z;ure threshold observed in the 
chronically treated mice must be attr1.buted to the abrupt withe:. 
drawal of phenaglycodole 
4. Discussion 
The data presented in these studies indicate that tolerance 
and physical dependence develop to the chroniC administration of 
large doses of phenaglycodol o Talers.nee 15 manifested by the 
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Figure 4. Effects of chronic adminlstra>tlon of phensJglycodol 
on threshold for pentylenetetrazol se1.zuIlIes in mice. Time in da.ys 
1s indicated on the abscisss... Seizure threshQld r~at10 (threshold 
drug group/threshold control group) is showl on the uppe .... ordins,te 
a.nd total daily dose of phenaglycodol admln1.stered 1s shown on the 
lower ordinate. Vertica.l br8,cketed lines lndi,ca te 95% f1ducial 
limits. A indicates the ratio 1 hour after the 8 a.m. dose; Band 
C indicate the ratio 8 hours after the midnight dose; D, E, F, G, 
and H indicate the ratio 12, 36, 60, 108, and 156 hours, respec-
tively, after the final dose of drug. The t in the upper r1ght~ 
hand corner illustrates the duration (hours) of the effect of a 
Single dose of phenaglycodol (300 mg/kg) on pentylenetetrazol seizure 
threshold in non-tolerant mice. 
;, that the EST= and ing effect. of :-~OO Ing/!l{~ of phena ... 
glycodol is reduced by 50% and 3605%.9 re;spectivelyo ""4180, as in 
the case of chronic tlra,tion depre~ 
effect of 200 mg/kg of ph€Jna,glycodol appeared less pronounced as 
the chrJonlc treatment progres~E~d,u Physical dependence is demon= 
j~ tra.ted by wi thdr>'8,gal hyperexci tabili ty $ 8 hours B"fter the final 
dose of phenaglycodol the EST=-ratio ~'(as only 00 (see D~ figure 
3) and 12 hours after the final dose of drug the PST=ratl0 was 
only O.B! (see D~ flgur;e 4)0 In e.ddition 9 it was observed that 
the phenaglycodol<=treated mice ma.nifested increased pre1nJectlon 
irr1tabl11ty as drug trea.tment continued. Since the EST a.nd 
were not reduced 8 hours and 12 hours 9 respectlvelYj after the 
acutve administra,tlon of 300 mg/kg of phenaglycodol to non= toler= 
ant mice (see inset 9 figures 3 and 4~ respectively)~ it must be 
concluded that the reduction in both electroshock= and c.hemo8hock= 
sei,zuI'e thresholds represent wi thdra"wal hyperexci t~abi,ll ty attr1= 
buta.ble to chronic treatment w1'th this drJug. 
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c. The Effects of Promazine (Sparine) 
on Central Nervous System Excitability of Mice 
1. Introduction 
A number of investigators (Hankorf at al., 1957; Bares and 
Kline, 1957; Voegele and May, 1957; Kurtzke l 1957; Cares at al., 
1957; and Shaw at al., 1959) have reported the occurrence of con-
vulsive seizures in nonep11ept10 patients during intensive 
therapy with phenothiazine derivatives. Meszaros and O'Reilly 
(1956) and Szatmarl (1956) concluded that chlorpromazine tends 
to decrease seizure threshold in epileptic patients and Fazekas 
and assooiates (1957) Buggested that large doses of chlorpro-
mazine and promazine have the capacity to induce seizures, par-
t1cularly in susceptible indivIduals. Fabisoh (1957) demon-
strated that chlorpromazine in doses of 0.3-0.5 ms/kg body weight, 
administered intravenously, can increase abnormal activity in the 
electroencephalograms of ep1leptic patients; indeed, he suggested 
that chlorpromazine should be useful as an activating drug in 
clinical electroencephalograph1c work. 
In animal studies l Essig and Carter (1957) induced con-
vulsions in normal monkeys by the chronic administration of 44-77 
mg/kg of chlorpromazine. Das and co-workers (1955) observed that 
the intravenous injection of chlorpromazine (0.2-0.5 mg/kg) in cats 
with midbrain transactions resulted in transient high voltage spike 
and wave discharges similar to the electroencephalographic charac-
teristics of petit ~ ep11epsYJ these workers also reported that 
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the injection of chlorpromazine in cats with the basis pedunculi 
intact ("pyramidal cats") resulted in occasional convulsions. 
Kopelofr and co-workers (1955) demonstrated that chlorpromazine, 
injected intravenously into monkeys with induced-brain lesions, 
accentuated focal spike and wave electroencephalographic activity 
and, on some occaSions, also induced "spontaneous" seizures. 
These investigators also faand that, after pretreatment with 
chlorpromazine~ smaller doses of pentylenetetrazol were required 
to provoke seizures in brain-damaged monkeys. Heming and co-workers 
(1956) observed that the electroshock seizure threshold in rats was 
lowered after chlorpromazine administration and Tedeschi and co-
workers (1958) reported that the phenothiazine derivatives, 
chlorpromazine, promazine, promethazine, and mepazine produced a 
significant decrease in minimal electroshock (alternating cur-
rent) seizure threshold in mice. Fink (1958) demonstrated that 
chlorpromazine, promazine, and trirlupromazine lower EST. 
Because certain central nervous system st~ulants, such as 
amphetamine, induce depression and somnolence upon abrupt with-
drawal (Knapp, 1952; Monroe and Drell, 1947) and 'because certain 
phenothiazine dar1 ve~ tlves increase the axei ts.bil1 ty of the can tral 
nervous system of humans and ex,per1m.ental a.nimals" it was of' inter-
est to invest1.gate the effects of chronic administration a.nd abrupt 
withdrawal of promazine. Promazine wa.s selected for this study be-
cause of its comparatively short duration (12-24 hours) of threshold-
lowering activity (Fink, 1958). It was thought that the withdrawal 
effects of a longer-acting phenothiazine derivat1,ve (e.g. chlor-
promazine) might be :masked by the extended action of the drug. 
2. Methods 
population sample of 100 mice 2 .0 to 3000 g in .eight~ were 
randomly divided into 2 equal groupso Promaz1ne~ as an aqueous 
solution, was initially administered to 1 group of mice in a 
total daily dose of 50 ms/kg (25 mg/kg at 8 a.m. and 8 pom o ) 
for 12 dayso On day 13 the 8 pom. dose was omi.tted in order 
to prov1de a !4=hour period of abstinence for testing. On day 
14, each dose was increased by 50% to make a total daily dose 
of 75 ~/kg; this higher dose level was continued for 5 days. 
The other group served as a control~ and was given the requi~ 
site volume of water at the appropriate intervals. Low~fre­
quency EST were determined at the times indicated in the legend 
to figure 5~ and the EST ratios calculated. 
Acute administration o~e (E~1~~~1. A popu~ 
la.tion sample of m.ice" 22.5 tQ 33.0 g in weight Jl were ra~ndomly 
divided into 2 groups of approximately 50 animals each. One 
group of mice wa~ given orally a single 37.5 mg/kg dose of pro~ 
lI.B.,zine $ the other group served a~ a control and. wa,~ given 10 
mIl kg of watero The EST of 'both groups were determined 4, 48, 
and 120 hours after oral intubation and the EST ratios calculated 0 
Three days after the 120~hour threshold determination, drug and 
w8,ter trea.tment were repea.ted in the same groups or mice and, the 
EST were determined for the 24= and 72~hour intervals and the EST 
ratios calculatedo 
2,Eronic a.dministration of<=prom~~i!le=~PST test]. A popu-
lation sample or 30 mice, 2500 to 2805 g in weight, were divided 
into 2 equa,l groups., Promazine ~'p"s inltiA.lly given to 1 group of 
mice in a total daily dose of 50 mg/kg (25 mg/k.g at 8 a.m. and 
8 p.m.) for 8 days. Following the 8 a.mo dose on day 8 each dose 
was in.creased by 50% so that a total daily dose or 75 mg/ke: was 
given; this higher dose level was continued for 12 dayso The 
other group served as a control and was administered the requl~ 
Site volume of water at the proper intervals. PST were established 
at the times indicated in the legend to figure 5, and the PST 
ratios calculated o 
Acute admipistratlon ~f ~!omazi~e_lP~T~estlo Twenty 
mice" 2500 to 3005 g in weight 3 were randomly divided into 2 groups 
of 10 mice each. One group was given orally 05 mg/kg of pro-
mazine and the other group was given the appropriate volume of 
water 0 PST was determined in both groups 1 and 24 hours after the 
drug trea t..'Ilent a.nd the PST ra tiOB calcllla ted. The procedUre was 
repea ted in 2 addi tional grou.ps of mice J) 
except that the PST were determined 48., 
after oral int'lbation. 
3. ReSlllts 
05 to 2900 g i.n weight, 
J 96~ 144 hours 
EST test o The acu administration of ~5 mg/kg of pro=-
mazlne decreased the ratio to 0077, 4 hOllrs after drug treat-
ment (see inset, figure 5); after chronic treatment for 15 daysJ 
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Figure 5. Effects of chronic administration of pro~qzine 
on threshold tor low-rrequency electroshock seizures in mice. 
Time in days is indicated on the abscissa. Seizure threshold 
ratio (threshold drug group/threshold control group) is shown 
on the upper ordinate and total daily dose of promazine adminis-
tered is shown on the lower ordinate. Vertical bracketed lines 
indicate 95% fiducial limits. A and C indicate the ratio 4 and 
!4 hours, respectively, after the 8 a.m. dose and B indicates 
the ratio 12 hours after the 8 p.m. dose. D, E, F, G, H, and 1 
indicate the ratio 24, 48, 7!, 120, 168, and 216 hours, respec~ 
tlvely, after the final dose of drug. The inset in the upper 
right-hand corner illustrates the duration (hours) of the effect 
of a single dose of promazine (37.5 mg/kg) on low-frequency 
electroshock seizure threshold in mice. 
0081 (see A, day 16, figure 5)$ Since the 2 
significantly different, tolerance to the 
are not 
lO'!?Jering effect 
of promazine either does not develop or CB.n not be dt~t,ected 
by the low-frequency electroshock seizure technic. Figure 5 
also shows that on day 14~ !4 hours after the 8 a~m. dose 
(see C, figure 5), and on day 20~ 48 hours after the final dose 
(see E, figure 5)3 the EST in mice chronically treated with 
pr~mazine was 1015 and 1 0 18 3 respectivelYa that of control 
animals. Since EST was not elevated 24 or 48 hours after the 
acute administration of a single 3705 mg/kg dose of promazine 
(see inset" figure 5), the increase in EST must 'be attributed 
to the abrupt w1thdrawal of this agentjJ 
PST ~~,",s~o Figure 6 shows tha.t tolerance to the pentyl-
enetetrazol seizure tbreshold~lowering effect of pronk~zlne was 
not detected by the PST test o This was demonstrated by the fact 
that the PST=lower1ng e.ffect of promazine was not diminished 
after chronic trea tment for 8 days l~i th 50 mgl/kg/day and then 
for 10 days wi th 15 mg/kg/day (see A:J d.ay 19 ~~ figur~e 6) 0 Figure 
6 also indioates tha.t 72 hours after the final dose of promazine 
(see E, figure 6):;1 tht~ PST ratio in chronically - tre,a ted animals 
WgS 1821. Since the PST ratto 72 hours after th(-,~ administration 
of 37.5 mg/kg of proma.,z1ne to the acu tely troated an .. imals l1as 
1.O~ (see inset" .figure 6) the elevt?tion in the PST ratio observed 
in the chronically treated animals must be attributed to the abrupt 
cessation of drug trea~ent~ 
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Figure 6. Effects of chronic administration of promazine 
on threshold for pentylenetetrazol seizure in mice. Time in days 
is indicated on the abscissa.· Seizure threshold ratio (threshold 
drug group/threshold control group) 1s shown on the upper ordinate 
and total daily dose of promazine administered 1s shown on the 
lower ordinate. Vertical bracketed lines indicate 95% fiducial 
limits. A indicates the ratio 1 hour after the 8 a.m. dose and B 
indicates the ratio 12 hours after the 8 p.m. dose. C, D, E, F 
and G indicate the ratio 24, 48, 72, 96, and 144 hours, respec-
tively, after the final dose of drug. The inset in the upper 
r1ght-hand corner illustrates the duration (hours) of the effect 
ot a single dose of promazine (37.5 mg/kg) on pentylenetetrazol 
seizure threshold in mice. 
4. Discussion 
The data presented in these studies indicate that although 
tolerance to the chronic administration of promazine was not 
detectable in mice by either the EST test or the PST test, a 
withdrawal effect was observed o Since an acute dose of pro~ 
mazlne produces an alteration of either the EST or PST which 1s 
oPPosite to that produced by an acute dose of either meprobamate 
or phenaglycodol, and since withdrawal of these latter drugs re-
sults in hyperexcitability, it 15 not unreasonable to anticipate 
that the abrupt withdrawal of promazine after a period of chronic 
drug administration would result 1n the appearance of hypoexcit~ 
ability; indeed this was the osseo Hypoexc1tability is demon-
strated by the fact that the EST-ratio was 10189 48 hours after 
the final dose of promazine (see Ep figure 5), and the PST-ratio 
was l.!l, 72 hours after the final dose of promazine (see E, 
figure 6). Since neither EST nor PST was elevated in acutely 
treated mice 48 or 72 hours after a single 3705 mg/kg dose of 
promazine, it must be concluded that the elevation in seizure 
threshold represents withdrawal hypoexc1tabi11ty attributable to 
the chronic administration of this agent. 
V. THE EFFECTS OF CHRONIC AND ACUTE 
ADMINISTRATION OF MEPROB~l\TE AND PRORA.ZINE ON 
ELECTROLYTE DISTRIBUTION IN MICE 
Ao Introduction 
In previous sections of this thesis, it was shown that the 
chronic administration of meprobamate decreased brain exc1tability 
and the abrupt termination of such treatment increased brain 
excitab1lity. In contrast, the chronic administration of pro~ 
mazine increased bra1n excitability and the abrupt termination 
of such treatment decreased brain excltabl11tyo Considerable In~ 
formation has been accumulated to indicate that changes in brain 
Na ratio (extracellular brain Na/lntraeellulnr brain Na) can be 
correlated with changes in brain excitabilityo Woodbury and co-
workers (Woodbury, 1954, 1955, 1958; Woodbury and Tlm1ras, 1957; 
Woodbury and Esplin, 1959; T~iras etal ol 1954J Timiras at a~o, 
1955; T1m1ras and Woodbury, 1956)~ employing either alternating-
current electroshock seizure threshold or low-frequency electro~ 
shock seizure threshold as a measure of brain function" demon-
strated that, under a. variety of experim{;ntal cond1t1ons, an l.n-
crease in the brain Na ratio results in a decrease in brain excita~ 
bi11ty, whereas a decrease in this ratio results in an increase in 
brain excitability. Thus, thyroidectomy, hypophysectomy, or treat~ 
ment with DCA, diphenylhydantoin~ or acetazoleamide results in an 
increase in brain Na ratio and a decrease in brain excltab111tyo 
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On the other hand, adrenalectomy or treatment with thyroxin or 
triiodothyronine results in a. decrease in the brain Na ratio B"nd 
an increase in brain excitability. In view of the marked effect 
of meprobamate and promazine on brain excitability and in view 
or the apparent role of sodium distribution in brain function, 
it was thought important to investigate the e£fects of acute and 
chronic administration of these agents and their abrupt with-
drawal on the distribution of brain electrolyte in mice. It was 
thought that these studies might contribute to an understanding 
of the mechanism of tolerance and physical dependence. 
B. Methods 
A population sample of 270 mice, 20.0 to 28.0 g in weight, 
were randomly divided into 3 groups or approximately 90 animals 
each. The first group was chronically treated with meprobamate 
and the second group was chronically treated with promazine, 
while the third group served as a control and was given the 
requisite volume of acacia solution. Meprobamate and promazine 
were administered daily in the same dose schedules as outlined on 
pages 21 and 37, respectively, except that no doses were skipped 
until withdrawal. Hence, the meprobamate~treated mice were 
initially given l200 ms/kg/day of drug (200 mg/ks at 8 a.m., 
12 noon, 4 p.m., and 8 p.m., and 400 mg/kg at midnight) for 6 
days and then 1800 mg/kg/day for an additional 10 days (each dose 
was increased 'by 50% following the 8 a.m. dose on day 7). The 
promazine-treated mice were initially given 50 mg/kg/day of drug 
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(25 ms/kg at 8 a.m. and 8 p.m.) for 13 days and then 75 mg/kg/day 
ror an additional 5 days (each dose was increased by 50% on day 
14). The third group served 8S a control for the first 2 groups 
and was given 10 ml/kg of acacia solution on the same dose sched-
ule &s the meprobamate-treated animals. The concentration of Cl, 
Na, K, and water in plasma and brain tissue (cerebral cortex) were 
determined at the time of peak threshold-raising action of mepro-
bamate (1/2 hour after drug treatment), at the time when hyper~ 
excitability was initially observed following the abrupt with~ 
drawal of meprobamate (4 hours after final drug treatment), at the 
time when hypoexcitabi11ty was initially observed following the 
abrupt withdrawal of promazine (48 hours after final drug treat-
ment), and at the time when seizure threshold had returned to normal 
(100 hours after final dose of meprobamate and 168 hours after final 
dose of promazine). Approximately 250 mice, 17.0 to 38.5 g in 
weight, were divided into 3 groups for the acute study. Mice 
acutely treated with a single dose of meprobamate (3~O mg/kg) were 
sacrificed for electrolyte and water determination at intervals of 
1/2 and 4 hours following drug treatment and an~als acutely treated 
with promazine (37.5 ms/kg) were sacrificed and examined at inter-
vals of 4 and 48 hours following drug treatment. Control animals 
were given the requisite volume of acacia solution or water and 
sacrificed for electrolyte and water determination at appropriate 
intervals. 
c= 46 CD 
Electrolyte determinations were performed on pooled samples 
comprising the plasma or tissue from 7 to 10 m1ceo Four such 
samples were used for each determination. The animals were anes-
thetized by the intraperitoneal injection of pentobarbital sodium, 
70 ms/kgl and blood was drawn from the abdominal aorta. The 
blood was centrifuged and an aliquot of the supernatant plasma 
was removed and analyzed for 01 concentration by means of a 
Cotlove Chloridometer (Laboratory Glass and Instruments Corp.), 
according to the method or Cotlove and co~workers (1958). The 
remaining plasma was analyzed for water~ Ha, and K content. Water 
content of plasma was determined by difference (wet weight minus 
dry weight). Aliquots of dried plasma were ashed, solub111zed l 
and analyzed for Na and K concentration by means of a Ba1rd~ 
Atomic Inc. Flame Photometer (model DB4) according to the method 
described in Appendix Ao After exsanguinatlon3 the mice were de~ 
capitated and the cerebral oortices were removed ror water and 
electrolyte analys8so Water content of brain was determined by 
difference (wet weight minus dry weight)o Approximately 50 mg of 
dried brain tissue were digested and analyzed for Cl content by 
the aethod of Van Slyke and Sendroy (1923)~ and a11quots of the 
remaining dried ti8sue were ash~d» solubilized and analyzed for 
Na and K concentrations by means o£ a flame photoaeter o The 
method af Has t1ngs and E1chelberger (1937) arld Manery and Has tinge 
(1939) was employed to calculate intracellu.la,r B,nd extracellular 
electrolyte concen,tratlonB o' The various technica.l procedures and 
method.s for ealculat1.ons are a,ascribed in dets,il in Appendix Ao 
Co Reau.lts 
The effects of a single dose of meproballB,te Of' promazine on 
the eoncentratlon of electrJolytes and 'water in plasma, and brain 
are summarized in ta,ble 1. The administration of a single dose 
of meprobamate (300 mg/kg) had no significant effect on the con~ 
cen tra tlon of elec tI~olytes or water in plasma or brain (F > .05 ) 
II! hour (time a t which the EST was increa.sed more than 10 fold) 
or 4 hours (time at which the EST had returned to normal) after 
drug treatment. Promazine (31.5 mg/kg) produced a significant 
decrease in the concentra.tion of plasma Na. (P<o05) 4 hours after 
drug adm1nistrat1.on (tim.e a.t which the EST was decrea.sed approxi-
mately !cy%) JP but caused no significant a.lteration in the concen-
tration of other ,plasma electr&olytes or water or in the concen-
tration of brain electrolytes or water 4 and 48 hours (time at 
which the EST had returllsd to normal) after oral intubation. 
The effects of chronic administration and abrupt withdrawal 
of meprobamate or prcJmazine on the concentration of electrolytes 
'and water in plasma and brain are summarized in table!. The 
chronic administration of meprobama.te altered the concentrati.on 
of plasma electrolytes only l/~ hour after the final dose of 
drug (time at whicn EST was increased 2.5 fold); thus, the con~ 
centration of plasma Na was si,gni.flcantly increased (P<o05) and 
the concentration of plasma. Cl significantly decreased (P<eOl). 
The chronic administrati.on of meprobamate a.ltered trJ.6 concentration 
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Concentration per kg 
Plasma 
mEq-'Na imEq X' mEq Cr-
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* 1.77 
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~igures in ( ) are P values for differences of results from those of the control group. 
b* Standard dev1ation of the mean. 





Effects of Chronic Administration and Abrupt Withdrawal of Meprobamate or Promazine a 
on Water and Electrolyte Concentrations of Plasma and Cerebral Cortical Tissue of Mice 
hr after Concentration per kg Concentration per kg 
final·~ Plasma Moist Cerebral Cortex 
treat- Procedure ID.r.;q .n8 mEqK mEq Cl g H~O mEq Na mEqK mEq Cl g H2O men;t 
1/2 Acacia 149.55b 3.19 1!1.96 937.0 45.91 111.11 30.08 777.7 (Control) 't' 0.54 %0.06 ± 1.72 -.t 2.0 iO.55 t 1.65 ±O.36 ~ 1.1 
1/2 Mepro- 151.38 t 3• 37 111.84 935.4 46.97 117.55 '27.44 170.4 bamate t 0.51 0.08 i: 1.89 r 3.6 ~O.36 t' 1.70 :to. 54 't 1.5 ( .05 ( .01 ( .05 ( .01 ( .01 
-.O!) -.001) -.02 ) ~.OOl) -.0011 
4 Acacia 152.51 3.15 113.14 231•4 44.84 94.27 28.48 783.4 (Control) ~ 0.46 to.1O r 2.65 
- 2.7 to.83 -t ~.29 to.52 ± 1.8 
4 Mepro- 151.53 3.16 114.69 r 4 •8 44.4~ 90.36 30.47 181.5 bamR.te T 1.55 to.11 -:t: 1.15 0.6 ~o.46 ± 1.g8 :to.55 ~ !.o 
( 0.5 
-0.2 ) 
48 Promazine 152.84 3.26 108.48 ¥32 .7 44.40 89.93 29.82 778.5 
r 0.87 to. 09 't 1.68 0.8 tl.Og * ~ 24 "tl.45 i 3.1 _. 
100 Acacia 151.89 3.68 115.40 934.4 44.40 J01.08 28.93 ISS.! (Control) i: 1.00 ~O.11 * 2.10 t 0.8 to.59 t 3.09 to.24 0.4 
100 Mepro- 150.40 3.65 114.66 934.2 44.75 +97.06 28.08 783.0 
bama.te r 0.63 -to. 12 f' 2.46 "t' 1.8 ±O.29 
- 1.19 *0.49 ~ 0.8 
I 
168 I Promazine 150.94 3.46 116.50 935.8 44.40 100.13 27.45 784.3 
- .•. --- .. --..... -- ............... 
i: 0.93 I iO.02 ~ 1.68 "t 2.0 "tl.38 -t !t.I_~_ *1.18 :t 0.6 
B-:F1gur'es in ( ) are P values for differences of results from those of the control group 
b' 
±" Standa.rd deviation of the me·an. 
increased 2.5 fold) and 4 hOU!V8 (tlma a.t which the EST was de=-
creased approximately 20%) after drug treatment, but had no 
signif1cant effect on the component~ studied at 100 hours (time 
at which EST had returned to normal). Thus~ the K concentration 
of moist bra1n was significantly increa.sed (P(.05) 1/2 hour after 
the final dose of meprobamate and was somewhat lower than control 
values at 4 and 100 hour~» the Cl concentration 'Vf8S,S signifIcantly 
decreased (F<oOl) at 1/2 hour and W8,S; significantly increased 
(P~.05) at 4 hours; and the we~t}e!r concentre<.t1on was significantly 
decrea.sed (P.(.Ol) at 1/2 hour ancl ,fas essentiHlly normal there-
after. Promazine tended to decrease the concentration of plasma 
Cl and brain K 48 hours after adm,1ni.stration of the final dose 
of drug (time a,t which the Iwas increa.sed approxima tely 2Cf!:,)!1 
but induced no other changes in the concentration of electrolyte 
or 1AtB. ter in pl8.3~ or brain at 48 or 168 hours (time a. t which 
had returned to normHl) Q 
The distribution of electrolytes and water in the intra; 
from the d Ci t~~, 
presented in tables 1 a.nd 2 by the method described by HE;,stings 
and co~workers (Ha~ting8 a,nd ~Elch·alber"ger$ ; M&"nery a.nd 
Has tings, 1939). Chloride space ~ whicrl \Was as~umed to be a. mea,Stll'l)e 
of the extracellular fluid volume s ,",as determined from the concen= 
trat10n of Cl in plasma and br&ain. Although chloride spR.ce is not 
identical wi th the extra.cellular 5pace, numerous inves tiga tor~· 
(Manery and Hastings, 1939; Winkler at a10, 1944 ; Swinyard, 1949; 
=0.;;. '=.. =-0-..,..... 
Nichols et.-..2±o, 1953; and Gotlove~ 1954) have concluded that changes 
-= 51 => 
in the ~ spaces are parallelo Therefore a chloride space offers 
a reliable index for estimating directional changes in the volume 
of extracellular fluid. 
The effects of a Bingle dose of meprobamate or promazine on 
the extracellular and intracellular distribution of electrolyte 
and water in cerebral cortical tissue are summarized in table 3. 
Except for the effect of meprobamate on brain K ratio at II! 
hour, brain 1ntracellalsr Na at 4 hours, and brain Na ratio at 4 
hours, a single 300 mg/kg dose of meprobamate or a single 31.5 
mg/kg dose of promazine had no significant effect on any of the 
calculated values for the distribution of electrolytes and water 
in cerebral cortical tissue. The significant changes (P~o05) 
induced by a 300 mg/kg dose of meprobamate include an increase in 
brain K ratio at II! hour, 8 decrease in the concentration of intra~ 
cellular Na in moist brain and in cellular water at 4 hours, and an 
increase in brain Na ratio at 4 hourso Although there appear to be 
changes in the calculated distrlbut10n of other electrolytes a.nd 
water which may be important.., the a.lterations lnduced were not 
significant. For example, after the administration of meprobamate 
the Cl space tended to be increaged at 1/1 and 4 hours, the concen~ 
tration of intracellular Na in moist brain and in cellular water 
tended to be decreased at 1/2 hour, and the brain Na ratio tended 
to be increased at II:! houro Aftero the administration of promazine 




Effects or a Single Dose of Meprobamate (300 mg/kg) or Promazine (37.5 ms/kg) 
on Extracellular and Intracellular Distribution of Electrolytes and water in Cerebral 
Cortical Tissue of Mice& 
----
Cl space Cl-free Intracell Na 
.Extraeell Intracell K Intra.ce11 Hr (extra- space mEqkg Intracell mEqkg Extracell 
after cell) (intra.., oe11- ce11-
treat- cell) moist ular Na moist ular K 
ment Procedure g/kg moist brain brain water brain water 
1/2 Aca.cia 222.1b 566.7 8.53 14.~8 11.82 102.68 181.20 50.3~ (control) ~ 6.7 i= 7.0 t2.00 ±3. 2 !;2.52 t 2.38 ± 3.84 %.0.6 
1/2c Mepro- 241.3 544.2 5.61 10.13 13.74 104.56 192 .46 56.48 
bamate ±12.9 ~t14.9 t2.13 %4.13 14.93 ± 2.53 t 7.47 -t2.60 ( .05- .02) 
.. 
4 Acacia 210.7 576.4 11.65 20.1~ 7.70 108.24 187.84 52083 (control) ± 3.4 ± 3.5 1:.0.54 'to.S to.35 ±" 2.05 ...r 4.50 %1.52 




( .05- .02) 
4 Promazine 216:3 570.ti 12.05 21.1l:: 7.26 108078 190.55 54.33 
t- 4.8 r 4.7 ~O.72 ..z1.34 to.47 ± 1.23 i: 0.99 :k2026 
48 Water 230.3 555.9 9.36 16.78 9.54 105.94 190.75 60.36 (control) i:lO.5 :tlOo2 tl.07 t1078 tl.27 1: 2013 ± 4.77 ±2.21 
48 Promazine 218.1 568.2 9.97 17.48 9.15 108071 191.35 55.73 
i: 6.3 t' 6.6 tl.32 i:2.11 to.88 ± 2.08 1: 3.19 j:2.05 
--~ '----------
---
L........-.. _ ..•........ _ ..... ~ .•. _._ 
._---
a Figures in ( ) are P values for differences of results from those of the control group. 
b+ Standard deviation of the mean. 
cThree samples were employed for this determination) 4 samples were employed for all 
other determinations. 
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The effects of chronic administration and abrupt withdrawal 
of meprobamate or promazine on extracellu.ls,r and intracellular 
distribution of electrolytes and water in cerebral cortical tissues 
are summarized in table 40 Neither the chronic administration of 
meprobamate or promazine nor their abrupt withdrawal had any signl~ 
flcant effect on the calculated values for the distribution of 
electrolytes and water in cerebral cortical tissueo Although 
there appear to be changes in the calculated distribution of other 
electrolytes and water which may be important, the alterations in-
duced were not slgnificant o For example» after the administration 
of meprobamate the Cl space tended to be decreased' at 4 and 100 
hours~ the concentration of intracellular Na in moist brain and in 
cellular water tended to be decreased a.t 4 hours, and the brain 
Na ratio tended to be increased at 4 houra e After the adminis= 
tra,tion of proma.zine the C 1 space tended to be increased a t48 
hours and tended to be decrea.sed a.t 168 hours, the concentration 
of intra.cellular N'a in moist brain and cellular water tended to be 
d.ecreased at 48 hours:9 and the brain Ha ra tic tended to be in= 




Effects of Chronic Administration and Abrupt Withdrawal of Meprobamate or Promazine 
on Extracellular and Intracellular Distribution of Electrolytes and Water in Cerebral 
Cortical Tissue of Mice 
C1 space C1-free In trace 11. N a Extracell Intrace11 K Intracell Hr (extra- space mEQ 'kg Intrace11 mEq/kg Extraeell 
after cell) (intra- cel1- ce11-
treat- cell) moist ular Ne. moist u1ar K 
ment Procedure g/kg moist brain brain water brain water 
1/2 Acacia 219.7 558.0 12.60 22~54 6.85 110.40 197.90 61.48 (control) t 5.08 ..t 4.7 ±1.08 r1.78 :1:0.54 1: 1.65 ± 3.47 -t1.62 
1/2 Mepro- 218.1 552.3 13.44 24.32 6.36 116.80 211059 62.07 
bamate :t 4.9 i: 4.8 to.63 rO.97 '10.26 ± 1.6g t 4.43 i1.B8 
4 ltcacia 223.3 560.2 10.13 17.98 9.43 93.56 166.99 52.11 (control) ~ 8.3 ± 6.7 :1:1.88 %3.15 i1.50 ± 2.29 t 3.10 to.go 
4 Mepro- 233.4 54801 8.13 14.84 10 0 66 89.60 163.55 50.49 
bamate ± 2.6 :to 402 :to.54 r1.01 :to.89 1" 1.95 ± 4.30 -to.57 
48 Promazine 239.1 539.4 7.20 13.34 12.19 89.14 165.76 50.29 
f: 8.7 *11.3 to.92 ±1.68 t1.36 ± 3.23 t 8078 -i3.79 
100 Aoacia 222.8 562.4 10.01 1707~ 8.93 100.24 178.24 47.66 (control) ± 5.4 :J: 5.3 t:1.15 tl.8 :t:O.72 t" 3.09 r 5.70 tr1.78 
100 Mepro- 217.9 565.1 11.44 20.15 7.87 96.25 170.78 46.16 
bamate :t 8.5 ± 807 rl.39 1:2.16 t0086 t. 1.65 t 4.11 't1.95 
168 Promazine 209.7 574.6 12.28 21.18 8.19 9~.40 172.7~ 49.13 
't1O.6 "t11.2 ±2.43 t:3.96 tl.71 i: .75 t 5.4 ~1.30 
--.. -~ 
&± Standard deviation of the mean. 
Do Discussion 
The results presented in the prece~ing 8ection indicate that 
except for the significant decrease In the concentration of plasma 
Na 4 hours after promazine, the administration of a single 300 
ms/kg dose or meprobamate or a single 3705 mg/kg dose of promazine 
induced no m.arked changes in the electrolyte and water concentra.-
tion of plasma a.nd brain in the time periods stud.led" In contra,at, 
electrolyte and water distribution in plasma and brain was markedly 
altered in the chronically=-treated animals 1/2 hour after a dose of 
meprobamate. No significant alteration in the concentration of 
electrolytes or water in plasma and brain occurred in the chroni~ 
cally-treated animals 48 and 168 hours atter the administration of 
promazine. 
The effects of meprobama.te» after a stngle dose or a.fter 
chronic treatment, on the EST and on the calculated dlstribution 
of electrolytes and water in brain tissue of mice are summarized 
graphical17 in table 50 It may be seen that 1/! hour after the 
administration of a single dose of meproba.,mateJ} the time at 'Which 
the EST wa~ increased more than 10 fold, the electrolyte pattern 
was charac terized. by a s ignifican t increase (F (005) of the brain 
K ratio. Whereas, 4 hOUI1)~ a.fter the administration of a. slngle 
dose of meprobamate, the time at which the EST was e$sentially 
normal, the electrolyte pattern was characterized by a significant 
increase in the brain Na ratio o In comparison, l/~ hour after the 













The Comparative E.ffects of Single~Dose and of Chronic Treatment 
with Meprobrunate on EST and on Brain Electrolyte Distribution in Micea 
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the EST was increased !.5 fold~ the electrolyte pattern was 
characterized by a significant increase in the concentration 
of plasma Na. At the 4-hou,r) period, in th.e chronleally ..... trea.ted 
animals, when the EST was decreased by approximately 2~, and 
at the lOO-hour period when the EST was essentially normal, 
there were no significant alterations in the electrolyte and 
water distribution in brain. It is obvious from table 5 that 
there is no consistent correlation between brain electrolyte 
alterations and brain excitability. Indeed, the increased brain 
Na ratio 4 hours after a single dose of meprobamate, at a time 
when the EST was essentially normal, appears to be contradictory 
to the accepted concept that an increased brain Na ratio is 
associated with an increase in the EST (decreased brain excita-
bility). Also, in the chronically~treated animals, 1/2 hour 
after the administration of meprobamate, at a time when the EST 
was increased 2.5 told, there was no change in the brain Na ratio 
and 4 hours after the administration of' meprobamate, a.t a time 
when the EST was decreased approxiDtely '20%, the brain Na ratio 
tended to be increased.. Woodbury (1958) has demonstrated that 
the rate of electrolyte exchange from plasma to brain extracellular 
space 1s d~layed by the blood-brain barrier. Hence, in view of the 
acute nature of the electrolyte studies after meprobamate treat~ 
ment, i.e. the relatively short time interval between drug adminis-
tration and sacrifice of the animals, it is probable that the 
seemingly anomalous brain Na ratio at the 4~hour tLme periods may 
be due to a lag in the movement of Na across the blood brain 
barrier and that the brain Na ratio observed at the 4~hour per~ 
iods may merely reflect brain function during the earlier inter-
va.ls of decreased bra.in tunctiono Comparison of the bra.in N'a 
ratio .... EST relation between ~1nglec..o>dose trea·tment and chronic 
treatment indicates a trend, which suggests that the chronic 
adm.inistration of meprobamate tend~ to dimlnish the ohanges in 
the brain He. ratio at the l/2~ and 4~hour time periods o It 1s 
tempting to speculate that this action ot aeprobamate on the 
brain Na ratio may be associated with the development of toler~ 
ance to the threshold-=ra1si.ng effect of this drug. 
The effects ot promaz1ne~ after a single dose or chronic 
treatment, on the EST and on the calculated distribution of 
electrolytes and water in brain tissue of mice are illustrated in 
table 6. It may be seen that although 4 hours after a Single dose 
of proD1&.zlne the EST was decreased approx.ima tely ~($ and 48 hours 
after abrupt withdrawal of the drug fro. ehronlcally~treated 
animals the EST is increased approximately 2($, there were no 
significant alterations i.n the brain electrolyte pattern. How .... 
ever, there was a tendency for the brain Na. ra.tio to be increased 
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EST was increased approximately !~o Although the increase in the 
brain Us ratio at this tLme period was not statistically signifi-
cant" it, nevertheleiHJ, suggests tha.t hypoexcitabl1ity which re-
sults from the abrupt withdrawal of promazine may, at least in 
part, be associated with an alteration in the brain Ha ratio. 
Woodbury (1959) is of the opinion that in acute electrolyte 
studies alteratians in the brain K rati0 are sometimes useful 
measures of changes in brain function, whereas under other con-
ditions alter~tions in the concentration of plasJUl, Na may reflect 
changes in brain function. Thus" an increase 1n the brain K ratio 
or in the concentration of plasma Na is associated with an in-
crease in EST, whereas a decrease in these values is associated 
with a decrease in EST. It can be observed from tables 5 and 6 
that" in general" alterations in the brain K ratio and concen-
tration of plasma Na tend to relate well with changes in the EST. 
For example, 1/2 hour after a single doae of meprobamate the in-
creased brain K ratio is associated with an increa.sed EST and l/! 
hour after meprobamate in ehronlcally=treated animals the increased 
concentration of plasma Na is associated with an increased EST 
(see table 5). Four hours after a single dose of promazine, the 
decreased concentration of plasma Na is associated with a decreased 
EST (see table 6). 
The accurate interpretation of data obta.ined from electrolyte 
stadias as presented herein is difficult and may be compromised by 
the time-curve of the experlments o Woodbury (1958) has succinctly 
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described some factors which compromise the results of brain 
electrolyte studies: the role of the blood-brain barrier is usually 
ignored~ calculations are based on the assumption that chloride 1s 
a measure of extracellular space without regard to the kinetics 
of the an1on~ and no distinction 1s made between the rapid and 
slow phase in the extracellular compartment ot brain tissue. The 
half time for equilibration of the rapid phase (plasma and brain 
extracellular space) 18 1 and II! hours and that for equilibra-
tion of the slow phase (brain extracellular space and glial tis-
sue) 1s 24 hours. T.hereror~~ ~t 1s obvious that most electro-
lyte st~d1es reported herein were done while brain water and 
electrolytes were in an unsteady state. 
VI • GENERAL DlSCUSSIOH 
The results of the electroshock and chemoshock studies show 
that aeprobamate increases the EST and PST in ai080 During 
chronic treatment I the EST- and PST-raising efrect Qf meprobamate 
was diminished, a response which indicates the development of 
tolerance. When chronic drug adainistration was abruptly termi-
nated the EST and PST were significantly decreased below normal l 
a response indicative of withdrawal hyperexcitability or physical 
dependence. Several recent laboratory and clinical reports cor~ 
relate well with these findings. For example, Essig (1958) ad-
ministered large daily doses of meprobamate to 4 dogs for 4 to 
6 months. Upon abrupt withdrawal of the drug, all animals ex-
hibited convulsions and 3 of these dogs died after 3 to 5 seiz~res. 
Greaves and West (1957) reported! patients who experienced grand 
mal seizures after termination of meprobamate medication. Inter-
pretation of the observations reported for 1 case is complicated 
by the fact that the patient received 15 ag/kg of chlorpromazine 
~ times daily following termination of meprobamate therapy, but 
the remaining patient received no medication dur1.ng withdrawal CJ 
Furthermore, these investigators also observed that therapeutic 
benefit from meprobamate diminished during drug treatment; this 
suggests that tolerance ~evelops to the drug 9 In a double blind 
study, Halzl1p and Ewing (1958) reported that of 47 patients who 
received 6.4 or 3.2 g of meprobamate daily for 40 days 44 patients 
exhibited abstinence symptoms when drug therapy was discontinued. 
Typical symptoms included insomnia, vomiting, tremors, muscle 
twitching, overt anxiety~ anorexia, and ataxia. Eight patients 
showed evidence of hallucinations with marked anxiety and 
tremors, a syndrome similar to delirium tremens, and 3 patients 
exhibited grand mal seizures. 
The electroshock and chemoshock studies revealed that the 
EST and PST responses to phenaglycodol are qualitatively very 
similar to those of meprobamate. For example, during chronic 
treatment the EST~ and PST~raising effect of this drug was 
diminished and when chronic drug treatment was abruptly termi-
nated the EST and PST were significantly decreased below normal o 
Hence, the results obtained indicate that phenaglycodol 1s cap-
able of inducing the development of tolerance and withdrawal 
hyperexcitability or physical dependence. Although there has 
been as yet no clinical reports describing physical dependence 
to phenaglycodol, the results of the present study suggest that 
the drug should be held suspect until adequate clinical evi-
dence proves that it is free from addiction liabillty. Because 
or the s1ailarlty in the withdrawal hyperexcitability induced 
in aice by the chronic administration of either phenaglycodol or 
meprobamate and the evidence that continued ingestion of large 
doses of meprobamate can cauae physical dependence in both animals 
and man~ precautions should be taken to minimize the development 
of physical dependence to either of these agents and the severity 
of the withdrawal symptoms. Thus, large doses of phenaglycodol 
or meprobamate should be avoided, if possible, and these drugs 
should be withdrawn graduallY3 rather than abruptly~ from 
patients who have Doen ingesting large doses chronically. 
The res~lt8 of the electroshock and cheaoshock studies 
indicate that promazine deCr&aS8S the EST and PST in aice (in~ 
creased brain excitability). Tbese findings agree well with 
clinical reports that certain phenothiazine derivatives, in~ 
eluding promazine, increase central nervous system excitability 
(Hankoff at al.~ 1951; Barsa and Kline, 1957; Voegele and May, 
1957; Kurtzke, 1957; Cares et al., 1957J Fazekas, 1951; and Shaw 
at al., 1959). In view of the withdrawal hypoexcltabl11ty ob-
served in mlce when chronie promazine treatment was abruptly 
terminated, it is possible that mental patients ander heavy 
phenothiazine therapy for an extended period of time may exhibit 
similar withdrawal hypoexc1tabl1ity which may be erroneously 
interpreted as a return of pretreatment symptomB o Such effeots 
could be aVOided by gradually withdrawing the drug when the time 
comes to discontinue therapy. 
The effects of a single dose of meprobamate or promazine and 
of the chronic administration of these sa.e agents on electrolyte 
and water concentration in plasma and cerebral cortical tissue 
were studied in an effort to reveal changes which might explain, 
at least in part, the phenomena of tolerance and physical depend-
ence. Before discussing the data obtained in these studies it 1s 
appropriate at this point briefly to review suggested theories 
for tolerance and physical dependenceo 
Many theories have been advanced to explain drug addiction, 
but none 18 entirely satisfactory and the .echanis. of drug 
tolerance and phyaical dependence 13 still obscure. Most of 
theae theories (eog. antltox1n~ cellular i .. unity, pathobio8i8, 
allergy, replaceaent of cell constituent, reversible coagulation, 
dual action theory, etc.) have been reviewed by Tatum and Seevers 
(193l)~ Kolb and H1 .. elabach (1936)$ Eddy (1941)>> Isbell and 
Fraser (1950) and Wikler (1950)0 It aay be of interest to 
.ention theories that have been preaented subsequent to these 
reviews. 
The concept that the development ot tolerance is due to an 
increased abi11ty to metabolize or inactivate a drug has been a 
controversial one. For exaaple, Gross and Thompson (1940) re-
ported that toleraat and non-tolerant dogs excreted about the 
sa.e proportion of the administered dose of aorpn1ne but the 
foraer excreted les8 "bound- aorph1ne than the lattero This 
report reopened the consideration that tolerant ani.ala are 
capable of destroying or inactivating a larger portion of the 
injected dose of aorphine than non~tolerant ani.als o S.ba8-
qaently, Za.der (195~) confiraed these findings in rats a and, 
in addition J deaonstrated that liver from tolerant rats have an 
increaaed ab1lity to conjugate aorphlne ~ vltroo In contrast, 
Cochin and co-workers (1954) reported no 8ignificant difference 
between the free~ and bo.nd~.orphine plasma concentrat1on-tiae 
curve. of tolerant and non-tolerant dogs after 8ubcutaneoua in~ 
Jectlon of the analges1c. They concluded that alterations in 
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the pattern of morphine excretion do not account for the develop-
ment of tolerance and physical dependence in dogs. On the basis 
of similar experiments on dogs and rats, Woods (1954) stated that 
to date no acceptable evidence has been presented to support the 
view that altered distribution or tate of morphine is associated 
with or responsible for the development of tolerance or physical 
dependence. 
Kas& (1956) demonstrated that electroshock and pentylene-
tetrazol seizures l which enhance the staining action of dye in 
the central nervous system after intravenous injection l can re-
duce or eliminate tolerance to the antitussive effect of codeine 
and morphine for several days. He therefore suggested that toler-
ance to the antitussive effects of codeine and morphine occurs as 
the result of a decreased permeability of the blood-brain barrier 
consequent to the repeated administration of these analgesics. 
However l he made no mention of the role of the blood-brain barrier 
on physical dependence. 
Axelrod (1956) reported that liver from rats tolerant to mor-
phine loses much of its ability to N-demethylate morphine, dilau-
did, and meperidine. Further l he demonstrated a parallelism be-
tween ability of analgesics to depress enzyme N-demethylation and 
their ability to induce toleranee l and observed that nalorphine 
which blocks the development of tolerance (Orahovats at 81., 
1953) also blocks the reduction of enzyme activity. On the basis 
of these observations he suggested that the continuous interaction 
of narcotic drugs with demethylation enzymes inactivates the latter. 
Thus, he reasons that if it is assumed that enzymes which 
N-deaethylate narcotic dr~gs are very siailar to the receptors 
for these agents» it m.ay be postulated that continued inter-
action of narcotic drugs with their receptors may inactivate the 
latter; hence, a decreased response or tolerance to the narcotic 
may develop as a result of unavailability of receptor sites. In 
connection with N=dem.thylation of .orphine~ Fraser and co=workers 
(1958) advanced the hypotheSiS that delMthylated aorphine, nor-
morphine, opposes the cellular ~counter=adaptations~ presumably 
, responsible for the morphine ab~tlnence syndrome. However~ in 
testing their hypothesilS" they observed that norDlorphine not 
only has the ability to suppress morphine abstinence symptoms, 
but that it is also capable of producing direct physical dependence. 
That the phenomenon of drug tolerance occurs at the cellular 
level has been postulated by a number of investigators. For exam-
ple, Hatcher and Gold (19!9) fOlAnd no difference 1n the ra.te of 
disappearance of morphine from blood between tolerant and non= 
tolerant dogs and postulated that tolerance 13 due mainly to in-
creased cellular re~i3tancee Schmidt and LiVingston (1933a) 
demonstrated that dogs chronically treated with aorphine become 
tolerant to the depresaor actton of the intravenously injected 
drug and suggested that this phenomenon is not pecultar to blood 
vessels j but ts sha.red by vasomotor and respiratory centers a.nd 
the cerebrWl. They also observed (Schmidt and Livingston, 1933b) 
that an -acute tolerance~ could be induced over a period of 3 
hours by the adainistratton of a large divided dose of morphine, 
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and suggested that the underlying cause must be the same in the 
2 cases. They postulated that the cause for the development of 
tolerance is due to a cellular change of an unknown nature, based 
upon the presence of a concentration of morphine that equals or 
exceeds a critical level; presumably, it makes little difference 
whether this critical level is attained by prolonged admints-
tration over weeks or months or by repeated massive doses over 
a short interval of time. As in the case of morphine, alcohol-
tolerant animals apparently do not have the ability to increase 
the rate of metabolism of alcohol (Newman and Cutting, 1935, 
1936; Newman and Lehman, 1938) or rate of excretion of alcohol 
(Gettler and Freireich, 1935). Consequently, Newman and Lehman 
(1938) suggested that acquired tolerance to alcohol is primarily 
a tissue tolerance; the cells of the central nervous system 
develop the ability to function more effectively at a given con-
centration of alcohol. Recently, McCormick and Kniker (1935) 
reported that tissues obtained from rats chronically treated with 
morphine or racemorphan (Dromoran) can grow in tissue cultures 
containing lethal concentrations of the analgesics. They concluded 
that cellular tolerance must represent homeostatic changes occurring 
within the cell. However, tissues from rats chronically treated 
with sodium amobarbital developed no tolerance to lethal concentra-
tions of the depressant. Also, no dependence to morphine, racemor-
phan, or sodium amobarb1tal could be demonstrated in tissue cultures. 
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The most acceptable theory of tolerance and physical depend-
ence is that they are cellular phenomena involving cells of the 
central nervous system. Hence, since Woodbury and co~workers 
(OP. c~t.) observed that the brain Na ratio (extracellular brain 
Na/lntracellular brain Na) is correlated w1th central nervous 
system excitability it was thought important to analyze the 
electrolyte distribution in brains of mice chronically treated 
with meprobamate and promazine in an effort to determine whether 
this ratio might be associated with withdrawal hyperexcitability 
and withdrawal hypoexcitabillty. The result of the electrolyte 
studies presented in table 4 indicate that a correlati.on between 
the brain la ratio and withdrawal hyperexcltab11ity~ 4 hours 
after the abrupt termination of chronic meprobamate adm1n1strat1on~ 
could not be established. Indeed, the data showed that 4 hours 
after the final dose of meprobamate the brain Na ratiO tended to 
be increased (see table 4), at a time interval when the EST had 
returned to normal (see E3 figure 1)0 Although this observation 
may appear to contradict the accepted concept that an increase 
in the brain Na ratio is associated with an increase in EST~ it 
is believed that the relatively acute nature of the electrolyte 
stud1es l 1 0 e o the relatively short time interval (4 hours) between 
the final dose of meprobamate and sacrifice of the animals, did 
not permit adequate time for a steady state of electrolyte distri-
bution to occur. On the other hand, comparison of the brain Na 
ratio-EST relat10n between single~do8e treatment and chronic treat-
ment indicates a trend, which suggests tbat the chronic admin1s-
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tration of mepro'ball.8.te tends to d111.tnish the chang~~ in the 'brain 
Na ratio at the 1/21= and 4=hour tl.m.e pertou3 a It is possible that 
this action of meprobamate on the brain Na ratio may be associated 
with the development of tolerance to the threshold=raising effect 
of this drug. The re~ntl ts obtained in the prom.'3.zine studies are 
suggestive of a correlation between an increase in the brain Na 
ratio (see table 4) and withdrawal hypoexcitability, as indi-
cated by an increase in the EST (see E, figure 5). ThUS, it is 
suggested that withdrawal hypoexcltability following chronic pro-
mazine treatment aay be due, at least in part6 to a change in the 
brain Na ratio. 
Woodbury (1958) has demonstrated that the rate of electrolyte 
exchange from plasma to brain extracellular space is delayed by 
the blood brain barrier. For this rea.son, accurate interpretation 
of the data o~tained from the electrolyte stUdies is difficult. 
The lag in movement of electrolytes across the blood brain 'barrier 
and the acute nature of these Btudies served to compromise the 
results. It is believed that $tudies of this type, which involve 
a. short interval between dru.g trea. tment and ~acrifice of the ani-
mals, can yield unequivocal informat:ion only when analytical pro-
cedures are designed which are indep'endent of electrolyte equi= 
lib.riwa between plasJU. and bra.in extracellular compartQlent or when 
methods for calculation a.re devised to correct for the errOr intro-
duced by the blood brain barrier. 
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Since the results of the eleotrolyte studies in the mepro-
bamate-treated animals is apparently contrary to the accepted 
concept of correlation between brain Na ratio and brain exclta~ 
billty, it might prove advantageous to employ a longer acting 
agent in this type of study. Hence~ phenaglycodol» a 8ubsti~ 
tuted dial with a longer action than meprobamate~ or a long-
acting barbiturate may be more useful for the study of the 
mechanism of physica.l dependenceo Since Woodbury and Esplin 
(1959) have reported a correlation between brain amino acid 
aetabolisa and brain excitab1lity, future investigations on 
mechanism of physical dependence should include the role of 
brain amino acids, for example~ gamaa~aminobutyric acid and its 
congeners, in this phenomenon. 
The practical application of the technics employed in these 
studies should not be overlooked o The data presented indicate 
that both the electroshock and the chemo~hock technics may prove 
usefUl for the detection of tolerance and withdrawal hyper-
excitability induced by the administration of large doses of 
drugs which depress the central nervous system o On the other 
hand, the same technics may prove useful for the detection of 
withdrawal hypoexc1tab1lity induced by chronic administration 
of large doses of drugs which stimulate the central nervous 
system. 
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In view o£ the fewer animals required without sacrifice of 
precision and the s1a11ar profile of actions obtained from mepro-
bamate, phenaglycodol, and promazine by the ~ procedures (intra~ 
venous pentylenetetrazol and low~frequency electroshock), the 
graded-response technic reported herein should lend itself to 
the routine screening of candidate drugs for physical dependence 
liability. It must be emphasized, however, that the predictive 
value of this test can be determined only after more laboratory 
and clinical results have been accuaulated o 
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VIIo StJM]\1ARY .AND CONCLUSIONS 
Low~frequency electroshock sei~ure threshold (EST) and 
pentylenetetrazol seizure threshold (PST) were employed to mea .. sure 
the effects of chronic. admlnist~ra.tion of meprobamate (M11toWI1, 
Equan11), phenaglycodol (Ultra.n)" and promazine (Sparine) and of 
their subsequent withdra.al on the central nervous system in mice. 
To provide a basis of reference, the effects of s1ngle doses of 
these same agents on brain exclta.b11i ty, as m.easurjed, by the EST 
and PST tea ts 3 weI~e alao e8 tima ted. The EST wa.s determ.ined by 
means of a Gra.ss stimulator (model S4B)o The stimulus pars.meters 
employed consist of unidirectlonal pulses of Oo'! millisecond dur-
ation delivered for 3 aeconda~ through corneal electrodes~ at a 
frequency of 6 pulses per ~econd 8 The PST was determined. by the 
intravenous infusion of a Oo5~ solutlon of pentylenetetrazol a.t 
a ra.te of. 00005 11.1 per second until each mouse exhibits persistent 
clonus for 3 seconds 0 The anima.ls were chronically tree. ted for 
.! to 3 weekS; drug admin.is tra tlon was a.bruptly terminated and the 
EST and PST were measured at predetermine"" periods. The results 
obta.1ned. were expressed as tbreshold ratios (threshold drug group/ 
threshold control group)o 
The acute administration of a. single 300 mg/kg dose of mepro,,-,-
bamate increa.sed the E8T=ratio more than 10 fold a.nd the PST=ratl0 
4.5 fold 1/2 hour a.fter drug treatment,; wherea,s/j after approxi= 
mately ! weeks of chronic treatment with meprobamate a this ssme 
dose of drug increased the EST=ratlo only !o5 fold and the PST=-
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ratio only 209 fold o ThuB$ tolerance develops to the threshold ..... 
raising effects of mepr'obaJl1s ttl 0 Four hours a.fter the final dose 
ot meprobama.te in the chron1cally<=treated animals, the EST=ratio 
was somewhat less than 0.8 and the PST-ratio was 008~o Since the 
EST and PST 4 hours after the administration of a 300 as/kg dose 
of meprobamate to non<='t,olerant a.nlma18 were the same as the thres-
holds of control animals 9 the reduction in the seizure thresholds 
observed in the chronlcallyc;;;>treated animals BlUst be attri'buted to 
the abrupt withdrawal of meprobamate. 
The chronic administration of phenaglycodol and its abrupt 
withdrawal produced responses which essent1allyparalleled those 
produced by meprobamateo Acute admin.1strat1on of' a single 300 
mg/kg dose of phenaglycodol increased the EST=rat10 307 fold and 
the PST-ratio 1.4 fold 1 hour after d.rug trea.tment,; whereas, 
after approximately! weeks of chronic treatment with phena~ 
glycodol~ this same dose of drug increased the EST~rat10 only 1.9 
fold and the PST=ratio only 401 fold. TtlUS, tolerance develops 
to the threshold...,ra.1sing effects of phenaglycodol o After the 
final dose of phenaglycodol in the chron1cally~treated animals, 
the EST=ratl0 at 8 hOUI1)S was 0081 and the PST=rat10 at 1,2 hours 
was o.8!. Since the t,hresholds after the administration of a 
single dose of 300 ag/kg of phenaglycodol to non~tolerant animals 
were .!.! fold at 8 hours for the EST<=rat10 arid normal at l! hours 
for the PST~rat103 the reduction in seizure thresholds observed in 
the chronically-treated animals must be attributed to the abrupt 
withdrawal of phenaglycodol. 
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The a.cute administration of a single 37.5 mg/kg dose of pro-= 
mazlne to mice decreased the EST=ratio to 0.17 at 4 hours and de-
creased the f"ST=ratio to 0085 at 1 hour. Arter a,pproxlmately ! 
weeks of chronic treatment with promazine, the EST=rat10 was 0.81 
at 4 hours and the PST~ratio was 0076 at 1 hour after promazine 
treatment. Since the EST= and PST~ratlos of the acutely- and 
chronically=treated animals do not differ a the results suggest 
that tolerance either does not develop to the threshold=lower1ng 
effects of promazine or can not be detected, by the technics em=-
played. After the fina.l dose o.r promazine In the chronica.lly.,. 
treated mice, the EST~ratio was 1018 at 48 hours and the PST-ratio 
was 1.21 Bit 7! hours after the fl,nal dOBe or proD18.zineo Since the 
ESTc=rat10 a.nd the PST,,~ra.tio were not elevated s.t 48 and 72 hours., 
respectively, after an acute dose of promazlne~ the increase in 
the seizure thresholds in the chron1cally=treated animals must be 
attributed to the abrupt withdrawal of promazineu 
Thus" the EST B,nd PST studie($ lndicate that the chronic adminis= 
tI~a.tion of large doses of m~probB..mat'e or phenaglycodol result in the 
development of tolerance and physical dependenceo Tolerance is 
manifested by a reduction in the seizure threshold~ra1s1ng effects 
of these! agents. Physioa.l dependence 1.8 manifested by withdrawal 
hyperexc1 tab111 ty, as indicated by a decrease in 'ESIT and PST 0 The 
chronic adm.inistra,t1on or relatively large domes of promazine does 
not induce tolerance development~ but produces phySical dependence. 
Physical dependence to proma:z;ine 13 manifested by withdrawal hypo=> 
excitability as indicated by an increase in EST and PSTo On the 
basis or clinical report~ on central nervous system depressant 
and exci tant drugs and on the 'bars1.$ of the resul ts obtained in 
the present studies$ it is suggested that agents which tend to 
depress the central nervous system when administered tend to in~ 
duce withdrawal symptoms characterized by hyperexcitability, 
whereas, agents which tend to stimulate the central nervous system 
when adIl.lnistered tend to lnduce withdrawal symptoll~ chara.cterized 
by hypoexcitabilityo 
Since a decrease in the brain Na ratio (extracellular brain 
Na/intracellular brain Na) can be correlated with an increase in 
brain excitability and a.n increa.se in the brain Na ratio can be 
correlated wi th a decrease in brain exci ta'blli ty ~ 1 t wa~ though t 
important to investigate the errect$ of acute and chronic adminis~ 
tration and abrupt w1.thdrawal of meprobamate and promazine on the 
distribution of brain electrolyte in mice e It was believed that 
such a. study may contrl'b'U,te to an understanding of the mechanism 
of physical dependence. The result~ of the electrolyte studies 
in acutely~treated animals indicate that the brain Na ratio 
tended to increaae l/! hour after meprobamate and became sign1fl= 
cantly increa.sed (F<.eO,5) at 4 hourso In the chronically=treated 
animals, the brain Na ratio tended to be increased 4 hours after 
the final dose of meprobama.te, at a time interval wflen brain 
exci tabili ty W8.3 increa.sed, according to the EST determtna. t10n 0 
This seemingly anomalous respon~e 1s probably due to a lag 
period in the exchange of electrolytes between plasma and the 
extracellular compartm.ent due to the blood-bra.in barrier. That 
is, the animals were analyzed before a steady state of electro-
lyte distribution occurred and the brain Is ratio ob~ 
served at a tiDle when the EST was either normal or decreased is 
probably a reflection of the prevlou,s interval when brain function 
wa.s depressed. In the comparison of the: acutely=> and the chroni.,." 
cally~treated animals 3 a trend was observed in which the brain Na 
ratio in the latter anima.ls at the 1/2= and 4=>hour time periods 
was diminished. Henee, it 1s tempting to speculate that an 
alteration in the brain Na. ratio may be 8.ssociated wi th the de .... 
velopment of tolerance to the seizure threshold=ra1sing effect 
of meprobamate. In the case of the animals chronically treated 
w1 th promazine., the brain Na ra,tio tended to inerJease 48 hours 
after the final dose of drug o This observations although not 
statistically significant, corli)ela,tes well with 'ttiJithdrawal hypo= 
exei tabil1 ty as demonstrated by an increa,se in the EST at this 
time period. It is suggested that withdrawal hypoexcitability 
in the promazine~treated animal~ may be due, at least in part, 
to the increase in brain Na ratio Q 
Because of the complication engendered by the blood-brain 
barrier in electrolyte studies, especially those of an acute 
nature as described herein, ruture studies on the mechanism of 
physical dependence should employ agents which p08se8s a longer 
time of action than meprobamate» such as phenaglycodol or long-
acting barbiturateso A18o~ in view of the reported role or amino 
acid metabolism in brain £unction, future studies of this type 
should include the investigation of brain amino acid metabolism, 
such as gamma~aminobutyrle acid and its congenerso 
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VIII. APPENDICES 
A. Technical Procedures 
1. Procedure for obtaining blood 
~~~--... .... :~ ........................ ~-- ...... ~, 
APproximately 10 minutes prior to exsangulnation, each mouse 
1s anesthetized by the 1ntraper'i tonesl injection of f70 mg/kg of 
pentobarbital sodium (1.4% aqueous solution containing 10% 
ethanol). A 22 gauge, 3/4- or I-inch needle is placed on a ~3-ml 
syringe a.nd the plunger and barrel of the syringe ar'e sparingly 
moistened wi th a. heparin solution. Blood 1s dre",wn from the 
descending abdominal aorta of each mouse, a.nd the blood from 7 
to 10 mice 1s pooled in a test tube to form a single sample. The 
whole-blood sample 1s centrifuged and the plasma decanted. 
2. Determination of plasma chloride (Cotlove, Thrantham, and 
_. _ _ ........ _-...... ........ --=--.,_._' ................ ; ............................ --=,.~wc"..-..:-
Bowman, 1958) 
a. Procedure 
Preceding a series of analyses, the electrodes of the 
automatic chloride titrator (Cotlove Chloridometer, Laboratory 
Glass and Instruments Corp.) are first con(~ltiorled by the 
titrllation of a chloride standard; the first vB,lue obtained is 
usually low and is not recorded. Two blanks (4 ml of nltric-
acetic acid l'·ea,gent) a.nd 2 standards (0.1 ml of 160 mEq 
th 4 ml of r:~cid ti tra~ed at 
the beginning at the dotOl·";rij .. nr·~tlon~~, end 1. f G:'ch rftor ever-y 
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10 to 20 samples. The plasma samples are prepared by adding 
4 ml of the nitric-acetic acid l--eagent to 0.1 ml of plasma 
ill a giass titra.tlon vial. At the time of the titration, 
whether blank, standard, or plasma sample, 10 drops of 
gelatin reagent (approximately 0.5 ml) are added to the glass 
vial, which 1s then placed in position on the chloride ti-
trator. The rate switch is set on high and the titration 
switch is turned to position no. 1. When the indicator 
(black) pointer becomes stabilized, the adjustable (red) 
painter 1s set 10 microamperes above the indicator (black) 
pOinter. The timer is then set to zero and titration is 
begun by turning the titration switch to position no. 2. 
When the a.nalysis 1.8 completed., the timer 1s automatically 
stopped; the elapsed time is recorded. The vial 1s re-
moved from the titrator, the electrodes are rinsed with 
chloride-free w'ater and the procedure is repeated with each 
subsequent glass vial. 
b. Calculation of plasma Cl concentration 
~ a-.c ~~__ w= .. __ ... .., .a~ __ -
(1) Gross seconds ~ timer reading 
(~) Average net seconds of standards = (average gross 
seconds of stande:rds )-( averag0 gross seconds of 
blanks) = 62.09-0.97 = 61.12 
(3) Net seconds of plasma sample = (gross seconds of 
plasma sample )-(a.vere.ge gross seconds of blanks) :: 
46. ~O.97 = 45.88 
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(4) Factor ~ K = 
.1 of standard x concentration of standard) 
a.verage net secon S 0 standards· • 
0.1 x 160 • 0 2618 
61.12 • 
(5) Concentration of Cl, mEq/l plasma = 
K x ~net seconds of pla8ma samplej • 0.261 x 45.88 = 
(ml of plasma sample) 0.1 
120.11 
c. Rea.§.en ts 
(1) One-t~~hnorma1.nitI·lc_~cld-1Q% acetic aCid. One-
hundred ml of reagent grade glacial acetic acid 
and 6.4 ml of reagent grade concentrated nitric 
acid are added to 900 ml of water. 
(2) Gelatin reagent. (a) Gelatin (Knox unflavored 
gelatin), thymol blue (water soluble) and thymol 
crystals (reagent grade) were mixed in the propor-
tions of 60:1:1 by weight, respectively. (b) To 
6.2 g of the above dry mixtures l 1 liter of hot 
water 1s added and the mixture heated gently with 
continuous swirling unt1l the solution is clear. 
After cooling, the solution is stored in the refrig-
erator. (e) For each day's analyses, a new portion 
of the gelatin reagent is removed from the refrig-
erator and 11quified by immerSion in hot water. 
(3) Sodium ,chloride standard~ 160 mEgLl. Dried, 
reagent grade sodium chloride, 9.3520 g~1s dissolved 
in sufficient water to make 1 liter ot solution. 
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3. Determlnat12n . of J}!1smr:_ concentration of .!lB..te!,..!. p.otass.!~1 
and sodium 
a. ~rocedure for determination of plasma water . 
• >......-.~...... •• -------....... _------
A 1 ml aliquot or plasma is wei~ed in a tared platinum 
cx-ucible a.nd dried in an oven at 1050 C for 24 hours. After 
cooling, the crucible 1s aga1n we1ghed. The difference in 
weight represent mg of water per ml of plasma. This value 
mul'tiplied by l.Q2Q represents g of we. ter per 1 plasma,'. 
lOOO 
I Procedure ror det~rminatlon of plasma potas8i~.2nd sodium 
The plasma, dried as described above, is moistened with 
4 drops of concentrated sulfuric acid and the crucible is 
placed in a muffle furnace. The plasma is heated at 6500 C 
for 90 minutes. After the fUrna~e has cooled, the crucible 
is removed. One ml of concentra,ted hydrochloric acid is added 
to the crucible and slowly evaporated on a hot plate. The 
residue is then dissolved by the add1tion of 10 ml of a 
lithium chloride solution (10 mEq!l) to make a 1:10 dilution. 
A sample of this dilution (1:10) is then tested in the flame 
photometer (Balrd-Atomlc~ Inc., Model DB4) tor the concentra-
tion of plasma potassium. In addition, standard solutions 
containing 0.5 and 0.3 mEq/l of K are tested at the beginning 
of a series of determinations and arter every 3 to 5 samples. 
A 1 ml aliquot of the 1:10 dilution is then further diluted 
to 25 ml with the 10 mEq/l lithium chloride solution (final 
dilution is 1 :250). A sa.mple of this dilution is then tested 
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in the flanle photometer for plasma 'Na concentration. For 
plasma Na determinatlons~ standard solutions containing 0.7 
and 0.5 mEqjl of Na are employed. 
c. Calculation of plasma K concentration 
_ .,. u • 
(1) Galvanometer reading of sample = 565 
(~) Galvanometer reading of high K standard 
(0.5 mEq/l) ~ 800 
( 3) Gal vanome tar rea.ding of low K standard 
(0.3 mEqjl) : 480 
(4) Difference between concentration of high and low K 
standards = 0.5 - 0.3 = 0.2 
(5) Dilution factor = 10 
(6) Specific gravity of plasma: 1.008 
(7 ) mEqj 1 of K in dllu ten. sample :: 
lIT 1) - ~ 3ll x (11 
(2) - (3) 
0.3531 
t concentration of low standard = 
(8) Concentration of KJ mEq/kg plasma = 
(7)x.J2l II R.·P2.?1 x 10 : ~.50 
(6) 1$008 --
d. Calculation of plasma Na concentration 
. ,. .. ------ . .., . .... ~ 
Plasma Na concentration is determined by the same proce-
dure described for plasma K with the following exceptions: 
(1) Different concentrations of standard solutions are 
employed; 
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(2) A 1:250 dilution of plasma is tested on the flame 
photometer and the appropriate dilution factor (250) is 
substituted in the calculations (see above). 
e. Plasma Is and K standards 
'PF 
Elec trolyte Concentration of cation in mEqjl 
NaCl 0.7 0.5 0.3 
KCl 0.7 0.5 0.3 
LiCl 10.0 10.0 10.0 
4. Determination of brain tissue water, potassium, and sodium 
a. Procedure for brain water 
After exsanguination each mouse is decapitated and the 
cerebral cortex is removed for analysis. The brain tissue 
of 7 to 10 mice is placed in a tared glass vial and weighed 
(wet weight). The tissue is then dried at 1050 C for 4 
days. The tissue is again weighed (dry weight). The con-
centration of water in brain tissue is calculated as follows: 
g H20/kg wet brain tissue: (~~t weight - dry weight) x 1000) 
we'"£' we IgJit · 
b. Procedure for de~ermination of brain potassium and sodium 
The dried brain tissue is triturate~ by means of a glass 
rod, to a powder in the same glass vial in which the sample 
was dried. Approximately 50 mg of the powdered tissue are 
introduced into a platinum crueible~ moistened with 6 drops 
of 4N H2S04 and placed in a muffle furnace. The tissue is 
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heated to 6500 C for 24 hours. Two ml of concentrated Hel 
are then added to the crucible and slowly evaporated on a 
hot plate. The crucible is allowed to cool and the residue 
is dissolved in 5 ml of ion-free water. Four ml of the 
dissolved sample are introduced into a 25-ml volumetric 
flask and 5 ml of lithium chloride solution (50 mEqjl) 
are added. The contents of the flask is then diluted to 
25 m1 with ion-free water and tested on the flame photometer. 
The concentrations of K and Na are determined in the manner 
as previously described under plasma K and Na (see page 82 
The concentrations of electrolyte in the standard solutions 
are described under (e.) below. 
c. Calculation of brain tissue K concentration 
(1) Galvanometer reading of sample = 709 
(2) Galvanometer reading of high K standard 
(0.9 mEqjl) ft 804 
(3) Galvanometer reading of low K standard 
(0.7 mEqjl) = 642 
(4) Difference between concentration of high and low 
K standards = 0.9 - 0.7 : 0.2 
(5) Dilution factor: 31.25 
(6) 
(7) 
Weight of brain sample = 0.049 g 
Per cent dry weight of tissue : 
100.00 - liret weight - dry weight. 10~ = r wet weIght· x ~ 21.35% 
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(8) Concentration of K, mEq/l • 
17"
/ 1) - (3)~X 11 
.Il:!. r r ... concentra.tion of low standard -2 - (3 -
(701 - 642) x O.~ + 0·. 7 - 0 7827 
804 - 642 • - • 
(9) Concentration of K, mEq/kg wet brain tissue. 




0.7827 x 31.25 x 0.2135 = 
0.049 
d. Calculation of brain tissue Na concentration 
Brain tissue Na concentration 1s (calculated by the same 
procedure described tor brain K except that less concentrated 
standards are employed (0.2 - 0.5 mEqjl Hacl). 
e. Brain Na and K standards 
Electrolyte Concentration of cation in mEq/l 
NaCl. 0.9 0.7 0.5 0.3 0.2 
KCl 0.9 0.7 0.5 0.3 0.2 
LiCl 10.0 10.0 10.0 10.0 10.0 
5. Determination of brain tissue chloride (Van 8lyke and 
Sendroy, 1923) 
a. Procedure 
(1) Alku.li digesti0E, of tiS,su!!!. APproximately 50 mg 
ot dried brain tissue are introduced into a 25-ml 
. Erlenmeyer flask and moistened with 1 ml of IN 
KOH solution. The mixture 1s heated on a water 
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bath for 3 hours (small amount of ion-free water is 
added after approximately l.hour of heating)_ Two 
blanks, each consisting of 4 ml of IN KOH, and 2 
standard~each consisting of 4 ml of IN KOH and 
2 ml of a standard NaCl solution (approximately 
10 mEq/l), are also heated. After removal from the 
water bath, the solutions are cooled and neutralized 
with equivalent volumes of IN HN03- All 3 solutions 
(blanks, standards, and unknowns) are then assayed 
for chloride. 
(~) Assay for Cl. Three ml of O.025N AgN03 solution in 
concentrated HN03 are added to each Erlenmeyer flask. 
The solutions are then heated an additional 3 hours 
on a water bath, allowed to cool, and 6 ml of 5% 
ferric alum added. Finally, each solutton 1s ti-
trated with O.02N NH4SCN until a pink color persists 
for 15 seconds. 
b. C~lculat~on of brain Cl concentration (mEqlkg, wet tissue) 
Table 7. Values for Calculation of brain chloride concentration 
sample ml O.02N ml NH4SCN % 
weight NH4SCN blank - ml dry (g) NH4SCN weight 
Unknowr). 0.0514 3.370 0.359 21.35 
Cl standard 2.721 1.008 --_ .. (average) ~ .. ..,. .. 
Blank 3.729 (average) ---- .... - .... ----
6. 
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(1) The concentration of the standard Cl solution 
is multiplied by 0.002 and the product obtained is 
divided by the difference between ml NH4SCN solution 
used for the blank (3.729) and ml NH4SCN solution 
used for the standard (2.721): 
10.002 x 0.002 ~ 0.01985 = F 
1.008 
(2) The difference in ml NH4SCN solution used to titrate 
the blank (3.729) and the sample (3.370) is then 
multiplied by F: 0.359 x 0.01985 = 0.00712615 







(2) x % dry weight x 1000 = 
sample weight 
0.0071265 x (0.2135 x 1000) : 29.55 
0.0514 
calculation of intracellular a.ndaxtracellular sEaces 
. Defini t10n Method for calculation 
'mEq Na per a.s measured 
kg pla.sma 
mEq K per as measured 
kg plasma 
mEq Cl per as measured 
kg plasma 
g H20 per as measured 
kg plasma 
aThe subscript p refers to plasmal b to mOist cerebral cortex 
(braln)J e to extracellular, 1 to intracellular, and c to 
intracellular water. 
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(Na)e mEq Na per kg (Na)p x (0.95) x (1000) 
extracellular 
H2O (H2O)p 
(K)e mEq K per kg (K)p x (0.95) x (1000) 
extracellular (H20)p H2O 
(Cl)e mEq Cl per kg (Cl)p x (1000) 
H20 in plasma (H20)p x (0.95) 
(Na)b mEq Na per kg as measured 
moist cerebral 
cortex 
(K)b mEq It per kg as measured 
moist cerebral 
cortex 
(Cl)b mEq Cl per kg as measured 
moist cerebral 
cortex 
(H20 )b g H20 per kg as measured 
moist cerebral 
cortex 
(H2O) Cl space (extra- (Cl)b x (1000) e cellular space) (el)e 
(H2O) Cl-rree space intra- (H20)b - (H2O)e c cellular space) 
(Na.) eb mEq Na per kg (Na)e x (H2O)a moist brain, 
extracellular (1000) 
(Na)1b mEq Na per kg (Na)b - (Na)eb 
moist brain, 
intracellular 
(K) mEq K per kg (K)e x (H2O)e eb moist brain, (1060) extracellula.r 




(Na) c mEq Na per kg (Na)ib x (1000) 
intracellular H2O (H20)c 
(K)e mEq K per kg (K)1b x (1000) 
intracellular H2O (H20)c 
(Na)e 
bl'ain Na rat10 (Ha)e 




B. Statistical Procedures 
1. Graphic log-prob1t method for evaluating EST exper~ents 
(Litchfield and Wilcoxon, 1949) 
a. Determination of the CC50 and the rCe50 
The following is an example of the method employed for 
the determination of the CC50 and the fee50. The data shown 
in table 8 are taken from a typical experiment (EST 60 min-
utes after phenaglycodol, 200 mg!kg) as described in the 
General Procedure. 
Table 8. 
Values for calculation of (Chi)2 
Observed 
NUJDber Number Observed Ex~eeted Minus Con tributlo~s 
Volts Animals Seizures % % EX;2ected to (Chi) Tested Seizures Seizures (~bso1ute (Obtained from 
Value)' Nomograph 1) 
40 10 3 30 29 1 0.001 
45 12 6 50 50 0 0.000 
50 10 7 70 69 1 0.001 
55 10 8 80 82.5 2.5 0.003 
r 
The % of animals that exhib1ted seiZUres (observed %) 1s 
plotted by the dots in figure 7. A straight line (regression 
line is then visually fitted to the pOints. Expeoted % of 
seiZUres is determined by proJecting a vertical line from the 
observed % po1nt to the regress10n line. The point at which 
the vertical line intersects the regreSSion line 1s the 
-
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expected %. For example, the expected % of positive responses 
following st1mulation with 55 volts is 82.5% (as showr. by "XU 
in figure 7). The absolute difference between each pair of 
observed and expected % values is obtained and its contribution 
to (Chi)2 determined from nomograph No. 1 in the .original paper 
by Litchfield and Wilcoxon (1949). The values thus obtained 
constitute the figures in the right-hand column of table 8. 
The contr1butions to (Chi)2 are totaled and the sum (0.005) 
is multiplied by the average number of animals per dose (12.5). 
This is the (Chi)2 of the line. Ir the (Chl)2 of the line is 
less than the value of (Ch1)2 taken from table II of the 
original paper for 2 degrees of freedom (number of volts 
plotted minus 2 = 2) the data are not s1gnificantly hetero-
geneous, i.e. the line is a good f1t. In the present example. 
the product of 0.005 x 12.5 1s less than 5.99 (from table II 
of original paper), therefore, the data are not s1gnificantly 
heterogenous. The CC16, CC50, and cc84 are obtained from the 
dose (volt)-response curve, and the fee50 is calculated as 
follows: 
Slope funct10n : CC84/CC50! CC5Q/CC16 = 
55.5/45.0 + 45.0/36.5 = 1.23 
2 
fCC 50 =1. 23(2.77,f'N ) I where N 1s the number of animals whose 
expected effects are between 16 and 8~ 
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b. Ca.lculation of EST ratio (threshold dr\lg groUJ?L~re8hold 
~.~ntrol groupl 
(1) CC50 of control group z 17.4 volts 
(2) fCC50 of control group = 1.08 
(3) CC50 of drug treated group = 45.0 volts 
(4) tCC50 of drug treated group = 1.10 
(5) EST ratio = CC50 drug group/C050 control group = 
45.0/17.4 : 2.59 
(6) fEST ratio = 1.16 (obtained from nomograph No.4 of 
original paper) with the use of (2) and (3) above 
(7) The 95% fiducial limits tor the EST ratio are 
obtained by first div1d1ng and then by multiplying 
the ratio by the fEST as follows: 
Lower limit = EST ratio/fEST ratio = 
2.59/1.16 = 2.23 
Upper limit = EST ratio x fEST ratio. 
2.59 x 1.16 = 3.00 
Thus, the EST ratio and 95% fiducial limits = 
2.59 (2.23 -- 3.00) 
2" Analy!'ls of covariance method for evalua-tlng PS!.. .. e.xper1ments 
in mice 
The following is an example of the method employed for the 
ca.lculation of the PST rat10 (threshold drug group/threshold control 
group). The data employed a.re taken from a typical experiment 
(PST 60 minutes atter promazine, 37.5 mg/kg) as described in the 
General Procedure. The weights ot the mice and the experimental 
observations, as well as the logarithms ot these values, are 
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summarized in section a. below. These values are used to calculate 
the sums .. sums of squares, sums o:f products, and corrections for 
means of groups, which are summarized in section b. below. From 
the values shown in section b., the analysis of variance is 
completed in sect10n c. below and the PST ratio and its 95~ 
fiduoial limits are calculated in section d. below. Additiona.l 
details of the calculation may be found in Finney (1952), PP. 43-56. 
a. Weights, experimental o~servatlons .. and logarithms 
Bod.y Infusion 
Weight X Time Y 
n (g) (log g) (sec) (log sec) 
Group I: H2O (control) 
1 30.0 1.4771 52.5 1.7202 
2 27.0 1.4314 35.0 1.5441 
3 28.5 1.4548 35.0 1.5441 
4 29.5 1.4698 43.0 1.6335 
5 30.0 1.4771 53.0 1.7243 
6 27.0 1.4314 50.5 1.7033 
7 29.0 1.4624 38.0 1.5798 
8 29.0 1.4624 39.0 1.5411 9 28.5 1.4548 35.0 1.5 41 10 26.5 1.4233 46.5 1.6675 
Group II: Promazine, 1 hour after 37.5 mg/kg 
1 28.0 1.4472 29.0 1.4624 
2 25.0 1.397~ 27.5 1.4393 
3 29.0 1.462 '40.0 1.6021 
4 29.0 1.4624 41.0 1.6128 
5 30.5 1.-4843 39.5 1.5966 6 28.0 1.4472 32.0 1.5052 
7 27.0 1.4314 34.5 1.5378 
8 30.5 1.4843 39.0 1.5911 
9 28.5 1.4548 36.0 1.5563 
10 27.5 1.4393 38.5 1.5855 
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b. Sums, sums of squares, S~ of products and corrections 
for means 
Sums, sums of squares, and sums of products 
tx ~X2 ~(XY) 1:.Y ~y2 n 
Group I 14.5445 21.1577 23.6403 16.2520 26.4625 10 
Group II 14.5112 21.0634 22.4870 15.4891 24.0251 10 
Sum 29.0557 42.2211 46.1273 31.7411 50.4876 20 
Corrections for means 
(~X)2 In (tx)(~Y)/n (i:.y)2/n 
TOTAL 42.2117 46.1130 50.3749 
Group I 21.1542 23.6377 26.4128 
Group II 21.0575 22.4765 23.9912 
Sum. 42.2117 46.1142 50.4040 
t--
0\ 
c. Analysis of variance 
--
Source of Sums of squares and products Adjusted 
Varia.tion -2·. - - -2 d~f. ~(X-X) i(X-X) (Y-Y) Z(y-y) - 2 d.r. 1'<Y-Y) 
Between 1 .0000 .0012 .0291 1 .0258 
groups 
Within 18 .0094 .0131 .0836 
groups i 
Regression 1 .0182 
Error 17 .0654 
TOTAL 19 .0094 .0143 .1127 
--~--.--
b = regression coerricient =, .0131/.0094 = 1.3936 
~ 
Adjusted ~(y_y)2 = b2'(x_i)2 _ 2bi(x-i)(Y-Y) + ~(y_y)2 
Mean f p 
Square 
.0258 6.789 <.05 
.0182 4.789 <.05 
.0038 
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d. Summary of effect of promazine on PST 
Adjusted means 
-
- .. b(X-X) Y Ycorr Group X X-X 
I 1.4SJlS .0017 .0024 1.6252 1.6228 
II 1.4511 -.0017 -.0024 1.5489 1.5513 
Threshold ra.tio 
M = log thrahold 'ratio = Yllcorr - Y1corr = 1.5513 - 1.6228 = 1.9285 
R = threshold ratio = antilog of M = 0.848 
95% Fiducial limits 
f = 1 + .0000/.0094 = 1.0000 
V(YIcorr) = adjusted mean square for error/nr x f = .0038 
V(Y11corr) = adjusted mean square for error/nIl x f = .0038 
V(M) = V(Y1corr) + V(Y1lcorr) = .0076 
3M : VV(M) = .0276 
95% f1ducial limits for M : M ± (t. 05 x 3M) : 
1.9285 ± (2.011 x .0276) = 
1.8730 -- 1.9840 
95% f1ducial limits for R = antilog 95% fiducial limits for M = 
0.747 -- 0.964 
Therefore, the PST ratio and 95% f1ducial limits -
0.85 (0.75 -- 0.96) 
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3. Procedure for calculation of mean, standard deviation of 
mea.n" and "ttl test for significance 
a. Definition of terms 
x = individual observation 
n = number of observations 
s = sum. of 
i = S(x)/n = mean of observations 
S(x_i)2 = S~ of squares of deviation about mean 
S.D.x = 1S(x-x)2/n (n-l) = standard deviation of the mean 
b. Calculation of mean ~lus or minus standard deviation of ~," 
mean for 2 gr9ups of observations 
Plasma K (mE~kg) 
Group A Group B 
3.46 3.90 
3.71 3.81 
3.58 3.50 j.g8 3.32 
Sx 14.73 14.60 
n 4 4. 
- 3.68 3.65 x 
3x2 54.39 53.47 
(5x)2/n 54.24 53.29 
S(x_i)2 0.15 0.18 
n(n-1) 12 12 
S(x-x)2/n(n-l) 0.012 0.015 
S.D.- 0.11 0.12 
x 
x t S.D.- 3.68 ± 0.11 3.65 ± 0.12 
x 
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c. "t" test ror significant d1freren.c~ ~w!,en me.ans 
t : 
1/<1/nA + l/nB)@.(~A - xA)2 + S,(XB - ia):l 
, (nA - 1) + (nB - 1) 
3.68.- 3.65 
t = -;::========== ~/(1/4 + 1/4)(0.1, - 0.18) 
, (3 t 3) 
t = 0.03/0.17 = 0.002 
The t value calculated above is compared with a valuo 
obtained from a "t" table. The table 1s enter"ed with 
6 degrees of freedom (nA - 1) + (~ - 1) and the value 
2.45 (P of .05) is obtained. Since 0.002 1s less than 
2.451 the probability that the 2 means are not 
significantly different 1s greater than .05 (P7.05). 
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Low-frequency electroshock seizure threshold (EST) and 
pentylenetetrazol (Metrazol) seizure threshold (PST) were 
employed to measure the effects of chronic admin1stration of 
meprobamate (Miltown~ Equanl1)~ phenaglycodol (Ultran)~ and 
promazine (Sparlne) and of their subsequent withdrawal on the 
sensitivity of the central nervous system in mice. To provide 
a basis of reference, the effects of single doses of these same 
agen ts on brain exei ta bili ty, as measuI"ed by the EST and PST 
tests~ were also estimated. The EST was determined by means of 
8 Grass stimulator (model S4B). The stimulus parameters em-
ployed consist of unidirectional pulses of 0.-2 millisecond dur-
ation delivered for 3 seconds, through corneal electrodes~ at 
a frequency of 6 pulses perl second. The PST wa.s determined by 
the intravenous infusion of a O.5~ solution of pentylenetetrazol 
at a rate of 0.005 ml per second until each mouse exhibited per-
sistent clonus for :3 second.s. The anim.als were chronically-
trea ted for 2 to 3 weeks; drug admlnls tra tion lfJaS abruptly 
termina.ted and the EST and PST were measulied at predetermined 
periods f The r'esul ts obta.ined were expressed as threshold 
ra,tios (threshold drug group/threshold control group). 
The results of the electroshock and chemoshock studies indi-
cate that both mepr9bamate and phene.glycodol increa.sed :r:ST and 
PST. Chronic administration of either drug for approxlmsJtely 2 
weeks decreased the EST- and PST-raising effects of both drugs, 
i.e. resulted in the development of tolerance. When chron1.c 
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administration of either agent was abruptly terminated the EST 
and PST were decreased; this response was interpreted as with-
drawal hyperexcitability or physical dependence. In contrast, 
promazine decreased the EST and PST. Chronic administration of 
this drug over a period of approximately 3 weeks had no signifi-
cant effect on the EST- or PST-lowering effect. This observation 
indicates that tolerance to the threshold-lowering effect of pro-
mazine either did not occur or could not be measured by the ex-
perimental technics employed. Upon abrupt termination of pro-
mazine administration, the EST and PST were increased; this re-
sponse was interpreted as withdrawal hypoexcitability or physical 
dependence. 
The effects of a single dose of meprobamate or promazine and 
of the chronic administration of these same agents on electrolyte 
and water concentration in plasma and cerebral tissue of mice 
were studied in an effort to reveal changes which might explain, 
at least in part, the phenomena of tolerance and physical depend-
ence. The results of the electrolyte studies indicate that there 
is no consistent correlation between brain electrolyte alterations 
and brain excitability. Indeed, some of the altera.tions ir .. brain 
Na ratio were seemingly contradictory to the accepted concept 
that an increased Na ratio is associated with an increased EST. 
However, it was quite likely that the acute nature of the electro-
lyte studies, i.e. the short interval between drug treatment and 
sacrifice of the animals for analyses, may have compr'omised the 
results. Since the blood brain barrier retards the rate of electro" 
- 3 -
lyte movement from pla.sma. into the brain extracellula.l~ compa:.,"t-
mantI it was obvious that the electrolyte studies reported were 
done while brain water and electrolytes were in €In unsteady 
state. 
The data presented indicate tha.t both the electl~oshock and 
the chemoshock technics may prove useful for the determination 
of tolerance and withdrawal hyperexcita.bility induced by the 
administration of large doses of drugs which depresses the central 
nervous system. On the other hand, these same technics may 
prove useful for the detection of withdrawal hypoexcitability in-
duced by chronic administration of large doses of drugs which 
stimulates the central nervous system. 
